118 results on '"Kuyucu N"'
Search Results
2. International Nosocomial Infection Control Consortium report, data summary of 50 countries for 2010-2015: Device-associated module
- Author
-
Desse, J.E., Maurizi, D.M., Montanini, A.M., Chaparro, G.J., Stagnaro, J.P., Romani, A., Bianchi, A.C., Álvarez, G., Palaoro, A., Bernan, M., Cabrera-Montesino, R., Domínguez, C., Rodríguez, C.G., Silva, C.G., Bogdanowicz, E., Riera, F.O., Benchetrit, G., Perez, I., Vimercati, J., Marcos, L.S., Ramasco, L., Caridi, M., Oyola, M.C., Rodríguez, M.C., Spadaro, M.L., Olivieri, M.S., Saul, P., Juarez, P.D., Pérez, R.H., Botta, P., Quintana, D.Q., Ríos, A.M., Chediack, V., Chilon, W., Alsayegh, Ameena Isa, Yaseen, Fatema Hasan, Hani, Lateefa Fardan, Sowar, Saleh Fakher, Magray, Tahira Anwar, Medeiros, E.A., Alves De Oliveira, A., Romario-Mendes, A., Fernandes-Valente, C., Santos, C., Escudeiro, D., Azevedo-Ferreira Lima, D., Azevedo-Pereira, D., Onzi-Siliprandi, E.M., Serpa-Maia, F., Aguiar-Leitao, F., Assuncao-Ponte, G., Dos Anjos-Lima, J., Olszewski, J., Harten Pinto Coelho, K., Alves De Lima, L.F., Mendonca, M., Maciel-Canuto Amaral, M.L., Tenorio, M.T., Gerah, S., Andrade-Oliveira-Reis, M., Moreira, M., Ximenes-Rocha Batista, M., Campos-Uchoa, R.S., Rocha-Vasconcelos Carneiro, R., Amaral De Moraes, R., Do Nascimento, S.C., Moreira-Matos, T., Lima-De Barros Araujo, T.M., De Jesus Pinheiro-Bandeira, T., Machado-Silva, V.L., Santos Monteiro, W.M., Hristozova, E., Kostadinov, E.D., Angelova, K., Velinova, V.A., Dicheva, V.J., Guo, X., Ye, G., Li, R., Song, L., Liu, K., Liu, T., Song, G., Wang, C., Yang, X., Yu, H., Yang, Y., Martínez, A., Vargas-García, A.R., Lagares-Guzmán, A., González, A.P., Linares, C., Ávila-Acosta, C., Santofimio, D., Yepes-Gomez, D., Marin-Tobar, D.A., Mazo-Elorza, D.P., Chapeta-Parada, E.G., Camacho-Moreno, G., Roncancio-Vill, G.E., Valderrama-Marquez, I.A., Ruiz-Gallardo, J.E., Ospina-Martínez, J.O., Osorio, J., Marín-Uribe, J.I., López, J.C., Gualtero, S., Rojas, J.R., Gomez-Nieto, K., Rincon, L.Y.M., Meneses-Ovallos, L., Canas-Giraldo, L.M., Burgos-Florez, L.D., Amaral-Almeida Costa, M., Rodriguez, M., Barahona-Guzmán, N., Mancera-Paez, O., Rios-Arana, P.A., Ortega, R., Romero-Torres, S.L., Pulido-Leon, S.M., Valderrama, S., Moreno-Mejia, V.M., Raigoza-Martinez, W., Villamil-Gomez, W., Pardo-Lopez, Y.A., Argüello-Ruiz, A., Solano-Chinchilla, A., Muñoz-Gutierrez, G.A., Calvo-Hernández, I., Maroto-Vargas, L., Zuniga, M.A., Valverde-Hernandez, M., Chavarria-Ugalde, O., Herrera, B., Díaz, C., Bovera, M.M., Cevallos, C., Pelaez, C., Jara, E., Delgado, V., Coello-Gordon, E.E., Picoita, F., Guerrero-Toapant, F.M., Valencia, F., Santacruz, G., Gonzalez, H., Pazmino, L.N., Garcia, M.F., Arboleda, M., Lascano, M., Alquinga, N., Ramírez, V., Yousef, Reham H.A., Moustafa, Abd El Moniem, Ahmed, A., Elansary, A.M., Ali, Ahmad Mahmoud, Hasanin, Ahmed, Messih, Antoine Abdel, Ramadan, Arwa, El Awady, B.A., Hassan, D.M., Abd El Aziz, Doaa, Hamza, Hala, Agha, Hala Mounir, Ghazi, Islam Abdullorziz, ElKholy, J., Fattah, May Abdel, Elanany, Mervat, Mansour, M., Haleim, M.M.A., Fouda, R., El-Sherif, Rasha Hamed, Bekeit, S., Bayani, V., Elkholy, Y.S., Abdelhamid, Y.M., Salah, Zeinab, Rivera, D.M., Chawla, A., Manked, A.N., Azim, A., Mubarak, A., Thakur, A., Dharan, A.V., Patil, A., Sasidharan, A., Bilolikar, Anil Kumar, Anirban Karmakar, A., Mathew, A.M., Kulkarni, Anuja, Agarwal, Anuradha, Sriram, Anuradha, Dwivedy, A., Dasgupta, Arnab, Bhakta, A., Suganya, Arul Rose, Poojary, A., Mani, Ashwin Kumar, Sakle, Asmita, Abraham, Babu K., Padmini, Baby, Ramachandran, B., Ray, Banambar, Pati, Basanta Kumar, Chaudhury, Bhaskar Narayan, Mishra, Biraj Mohan, Biswas, S., Saibala, M. Bri, Jawadwala, Burhan Q., Rodrigues, C., Modi, Chirag, Patel, Chirag, Khanna, D.K., Devaprasad, Dedeepiya, Divekar, Deepa, Aggarwal, Deepesh G., Divatia, J.V., Zala, Dolatsinh, Pathrose, Edwin, Abubakar, Fazil, Chacko, Felcy, Gehlot, G.S., Khanna, Gautam, Sale, H.K., Roy, Indranil, Shelgaonkar, Jayant, Sorabjee, Jehangir, Eappen, Jincy, Mathew, Justin, Pal, Jyotishka, Varma, Karthikeya, Joshi, Kashmira Limaye, Sandhu, Kavita, Kelkar, R., Ranganathan, Lakshmi, Pushparaj, L., Lavate, Madhav, Latha, Madhavi, Suryawanshi, Madhupriya, Bhattacharyya, M., Kavathekar, Maithili, Agarwal, Manoj Kumar, Patel, Mayur, Shah, Mehul, Sivakumar, M.N., Kharbanda, Mohit, Bej, Mrinmoy, Potdar, Mrunalini, Chakravarthy, M., Karpagam, M., Myatra, S.N., Gita, N., Rao, N.P., Sen, N., Ramakrishnan, N., Jaggi, N., Saini, N., Pawar, N.K., Modi, Nikhil, Pandya, Nirav, Mohanty, Nisith, Thakkar, Pooja, Joshi, Pradnya, Sahoo, Prafulla Kumar, Nair, Pravin Kumar, Kumar, Priyadarshini Senthil, Patil, Priyanka, Mukherjee, Purnima, Mathur, P., Shah, Purvi, Sukanya, R., Arjun, Rajalakshmi, Chawla, Rajesh, Gopalakrishnan, Ram, Venkataraman, Ramesh, Raut, S., Krupanandan, Ravikumar, Tejam, Reshma, Misra, Richa, Debroy, Ritesh, Saranya, S., Narayanan, Sajith, Mishra, Sanghamitra, Saseedharan, Sanjith, Sengupta, Sankar, Patnaik, S.K., Sinha, Saswati, Blessymole, Seelas, Rohra, Seema, Rajagopal, Senthilkumar, Mukherjee, Shanta, Sengupta, Sharmila, John, Sheeba, Bhattacharya, Shefali, Sijo, Bhattacharyya, Sinchan, Singh, S., Sohanlal, T., Vadi, Sonali, Dalal, S.S., Todi, S.K., Kumar, Subodh, Kansal, Sudha, Misra, Sudhjan, Bhattacharyya, Sudipta, Nirkhiwale, Suhas, Purkayastha, Sujit Kar, Mukherjee, Sujoy, Sahu, S., Sharma, Sunil, Kumar, Suresh, Basu, S., Shetty, S., Shah, S., Singhal, T., Francis, Thara, Anand, Thejasvini, Venkateshwar, V., Thomas, Valsa, Kothari, V., Velupandi, Kantroo, Vini, Sitohang, Gortap, Kadarsih, Retno, Sanaei, Anahita, Maghsudi, Behzad, Sabetian, Golnar, Masjedi, Mansoor, Alebouyeh, Masoud, Sherafat, Somayeh Jahani, Mohamed, Yassir Khidir, Al Khamis, Abdulrahim, Alsaadi, Adnan Soliman, Al-Jarie, Ahmed Abdoh, Mutwalli, Aisha Hassan, Rillorta, A.S.K., Thomas, Anumol, Kelany, Ashraf, Manao, Athena, Alamri, Dhaffer Moghram, Santiago, E.B., Cruzpero, E.P., Sawan, Fahad Ahmed, Al Qasmah, Fatima Abdullah, Alabdaly, Haeel, Al-Dossary, Hajer Am, Ahmed, Hala, Roshdi, Hala, Al-Alkami, Halima Yahia, Hanafi, Hana, Ammari, Hassan Eisa, Hani, Hatem Mohd Al, Asiri, Ibrahim A.M. Alzaydani, Mendoza, Jeffrey Asidera, Philipose, Jomol, Selga, Joy Ola, Kehkashan, Ghalilah, Khalid Mohammed, Redito, Leide Shyrine, Josph, L., Al-Alawi, M., Al-Gethamy, Manal Mansour, Madco, Marjory, Manuel, M.G., Girvan, M., Aldalaton, Mervat, De Guzman, M., Alkhamaly, Modhi, Masfar, Mohammad, Karrar, Mohammed Ahmed Ali, Al Azmi, Munayfa Musallam, Quisai, Myrna Lim, Torres, Myrna Misador, Al-Abdullah, N., Tawfic, Nader Ahmed, Elsayed, Nashwa, Abdulkhalik, Nawal Salah, Bugis, Nehad Abdulshakour, Ariola, Neilia Cardinal, Gad, N., Alghosn, Nesreen, Tashkandi, Nidal, Zharani, N. Al, De Vera, P.A., Krishnan, Radhika, Al Shehri, Raed Hassan, Jaha, Rasha Nour Aldeen, Thomas, Reny, Cresencia, Rhea Lynn, Penuliar, R., Lozada, R.V., Al Qahtani, S., Twfik, Sameh, Al Faraj, Sarah Hassan, El-Sherbiny, Sherin, Alih, Siti Jhulmina B., Briones, Solita, Bukhari, Syed Zahid, Alotaibi, Tariq Saad Abdulhadi, Gopal, Uma, Nair, Usha, Abdulatif, Wael Abdulrahman, Hussain, Waleed Mohd, Demotica, Wynndale Mae, Spahija, G., Baftiu, N., Gashi, A., Omar, Abeer A., Mohamed, A.M., Rebello, F.M., Almousa, Haifaa Hassan, Abdo, Naglaa Mahmoud, George, S.M., Khamis, Soad, Thomas, Suja, Ahmad Zaatari, A., Anwar Al Souheil, A., Ayash, H., Zeid, I., Tannous, J., Zahreddine, N.K., Ahmadieh, R., Mahfouz, T., Kardas, T., Tanzi, V., Kanafani, Z., Hammoud, Z., Dagys, A., Grinkeviciute, D., Kevalas, R., Kondratas, T., Petrovska, Milena, Popovska, Katja, Mitrev, Zan, Miteva, Zaneta Bogoevska, Jankovska, Katerina, Guroska, Snezana Tufekcievska, Gan, Chin Seng, Othman, Ainul Auzani, Yusof, Aliza Mohamad, Abidin, Anis Siham Zainal, Aziz, Fadzlina Abdul, Weng, Foong Kit, Zainol, Hasimah, Bakar, Kamal Bashar Abu, Lum, Lucy Chai See, Mansor, Marzida, Zaman, Mazuin Kamarul, Jamaluddin, Mohamad Fadhil Hadi, Hasan, Mohd Shahnaz, Rahman, Raha Abdul, Zaini, Rhendra Hardy Mohamad, Zhazali, Rosliza, Sri Ponnampala, Sasheela Sri La, Chuah, Soo Lin, Shukeri, Wan Fadzlina Wan Mohd, Hassan, Wan Nazaruddin Wan, Yusoff, Wan Nurbayah Wan, Mat, Wan Rahiza Wan, Cureno-Diaz, M.A., Aguirre-Avalos, G., Flores-Alvarado, A., Cerero-Gudino, A., Zamores-Pedroza, A., Cano-Munoz, B., Hernandez-Chena, B.E., Carreon-Martinez, C.C., Coronado-Magana, H., Corona-Jimenez, F., Rodriguez-Noriega, E., Alcala-Martinez, E., Gonzalez-Diaz, E., Guerra-Infante, F.M., Arteaga-Troncoso, G., Martinez-Falcon, G., Leon-Garnica, G., Delgado-Aguirre, H.A., Perez-Gomez, H.R., Sosa-Gonzalez, I.E., Galindo-Olmeda, J.A., Ayala-Gaytan, J.J., Rodriguez-Pacheco, J., Zamorano-Flores, L., Lopez-Pulgarin, J.A., Miranda-Novales, M.G., Ramírez, M., Lopez-Hurtado, M., Lozano, M., Gomez, M.E., Sanchez-Castuera, M.E., Kasten-Monges, M., Gonzalez-Martinez, M., Sanchez-Vargas, M., Culebro-Burguet, M.C., Altuzar-Figueroa, M.A., Mijangos-Mendez, J.C., Ramires, O.G., Espinosa, O.S., De Leon-Escobedo, R., Salas-Flores, R., Ruiz-Rendon, R., Petersen-Morfin, S., Aguirre-Diaz, S.A., Esparza-Ahumada, S., Vega-Gonzalez, S., Gaona-Flores, V., Monroy-Colin, V.A., Cruz-Rivera, Z., Bat-Erdene, A., Narankhuu, Batsaikhan, Choijamts, Batsuren, Tuvdennyam, Battsetseg, Batkhuu, Byambadorj, Chuluunchimeg, K.H., Enkhtsetseg, D., Batjargal, G., Bayasgalan, G., Dorj, M., Mendsaikhan, Naranpurev, Baatar, Otgon, Suvderdene, P., Baigalmaa, S., Khajidmaa, T., Begzjav, Tsolmon, Tsuyanga, Ariyasuren, Z., Zeggwagh, A.A., Berechid, K., Abidi, K., Madani, N., Abouqal, R., Koirala, Anjeela, Giri, Rashmi, Sainju, Samana, Acharya, Subhash Prasad, Ahmed, Abeera, Raza, Aun, Parveen, Azra, Sultan, Faisal, Khan, Maria, Paul, Nadeem, Daud, Nargis, Yusuf, Sana, Nizamuddin, Summiya, Garcia-Mayorca, E., Castaño, E.G., Moreno-Castillo, J.L., Ballinas-Aquino, J.M., Lara, L., Vargas, M., Rojas-Bonilla, M.I., Ramos, S.J., Mapp, T., De Iturrado, V., La Hoz Vergara, C.E., Linares-Calderon, C.F., Moreno, D., Ramirez, E., Ramírez Wong, F.M., Montenegro-Orrego, G.M., Sandoval-Castillo, H.R., Pichilingue-Chagray, J., Mueras-Quevedo, J., Aibar-Yaranga, K.F., Castillo-Bravo, L.I., Santivanez-Monge, L.M., Mayorga-Espichan, M.J., Rosario-Tueros, M.L.G., Changano-Rodriguez, M.V., Salazar-Ramirez, N.E., Marquez-Mondalgo, V.A., Tajanlangit, Anna Lyn N., Tamayo, Arnefelina S., Llames, Cristina Mari Jean P., Labro, Ever, Dy, Ana P., Fortin, J.D., Bergosa, L.D., Salvio, L.G., Bermudez, V., Sg-Buenaflor, M.C., Trajano, M.F., Mendoza, M.T., Javellana, O.P., Maglente, R.R., Arreza-Galapia, Y., Navoa-Ng, J.A., Kubler, A., Barteczko-Grajek, B., Dragan, B., Zurawska, M., Mikaszewska-Sokolewicz, M., Zielinska, M., Ramos-Ortiz, G.Y., Florin-Rogobete, A., Vlad, C. Daliborca, Muntean, D., Sandesc, D., Papurica, M., Licker, M., Bedreag, Ovidiu Horea, Popescu, R., Grecu, S.D., Dumitrascu, V., Molkov, A., Galishevskiy, D., Furman, M., Simic, A., Lekic, D., Ristic, G., Eremija, J., Kojovic, J., Nikolic, L., Bjelovic, M., Lesnakova, A., Hlinkova, S., Gamar-Elanbya, M.O., Supa, Namphon, Prasan, Pornpheth, Pimathai, Rungratchanee, Wanitanukool, Suthinee, Somabutr, Suwara, Ben-Jaballah, N., Borgi, A., Bouziri, A., Dilek, A., Oncul, A., Kaya, A., Demiroz, Ali Pekcan, Gunduz, A., Ozgultekin, A., Inan, Asuman, Yalcin, A.N., Ramazanoglu, A., Engin, A., Willke, A., Meco, Basak Ceyda, Aygun, C., Bulut, C., Uzun, C., Becerik, C., Hatipoglu, Cigdem Ataman, Guclu, Cigdem Yildirim, Ozdemir, D., Yildizdas, D., Ugurcan, D., Azak, E., Guclu, E., Yilmaz, Esmeray Mutlu, Sebnem-Erdinc, F., Sirmatel, F., Ulger, F., Sari, Ferhat, Kizilates, Filiz, Usluer, G., Ceylan, G., Ersoz, G., Kaya, G., Ertem, Gunay Tuncer, Senol, G., Agin, Hasan, Cabadak, Hatice, Yilmaz, H., Sungurtekin, Hulya, Zengin, Humeyra, Turgut, H., Ozgunes, I., Devrim, I., Erdem, I., Işcanlı, Inşa Gul Ekiz, Bakir, M. Mehmet, Geyik, M.F., Oral, M., Meric, M., Cengiz, M., Ozcelik, M., Altindis, M., Sunbul, M., Elaldi, N., Kuyucu, N., Unal, N., Oztoprak, N., Yasar, N., Erben, Nurettin, Bayram, Nuri, Dursun, Oguz, Karabay, Oguz, Coskun, O., Horoz, Ozden Ozgur, Turhan, Ozge, Sandal, Ozlem Sarac, Tekin, Recep, Esen, Saban, Erdogan, Selvi Yener, Unal, Serhat, Karacorlu, Sevim, Sen, Suha, Sacar, Suzan, Yarar, Volkan, Oruc, Yeliz, Sahip, Yusuf, Kaya, Zeynep, Philip, Anamma, Elhoufi, Ashraf, Alrahma, Hussain, Sachez, E., Perez, F., Empaire, G.D., Vidal, H., Montes-Bravo, L., Guzman Siritt, M.E., Orozco, N., Navarrete, N., Ruiz, Y., De Anez, Z. Duran-Gil, Van Trang, Dang Thi, Minh, Dao Quang, Co, Dao Xuan, Anh, Dinh Pham Phuong, Thu, Le Thi Anh, Tuyet, Le Thi Diem, Nguyet, Le Thi Thu, Chau, Ngo uy, Binh, Nguyen Gia, Tien, Nguyen Phuc, Anh, Nguyen Quoc, Hang, Phan Thi, Hanh, Tran Thi My, Hang, Tran Thi Thuy, Thu, Truong Anh, Thoa, Vo Thi Hong, Rosenthal, Víctor Daniel, Al-Abdely, Hail M., El-Kholy, Amani Ali, AlKhawaja, Safa A Aziz, Leblebicioglu, Hakan, Mehta, Yatin, Rai, Vineya, Hung, Nguyen Viet, Kanj, Souha Sami, Salama, Mona Foda, Salgado-Yepez, Estuardo, Elahi, Naheed, Morfin Otero, Rayo, Apisarnthanarak, Anucha, De Carvalho, Braulio Matias, Ider, Bat Erdene, Fisher, Dale, Buenaflor, Maria Carmen S.G., Petrov, Michael M., Quesada-Mora, Ana Marcela, Zand, Farid, Gurskis, Vaidotas, Anguseva, Tanja, Ikram, Aamer, Aguilar de Moros, Daisy, Duszynska, Wieslawa, Mejia, Nepomuceno, Horhat, Florin George, Belskiy, Vladislav, Mioljevic, Vesna, Di Silvestre, Gabriela, Furova, Katarina, Ramos-Ortiz, Gloria Y., Gamar Elanbya, May Osman, Satari, Hindra Irawan, Gupta, Umesh, Dendane, Tarek, Raka, Lul, Guanche-Garcell, Humberto, Hu, Bijie, Padgett, Denis, Jayatilleke, Kushlani, Ben Jaballah, Najla, Apostolopoulou, Eleni, Prudencio Leon, Walter Enrique, Sepulveda-Chavez, Alejandra, Telechea, Hector Miguel, Trotter, Andrew, Alvarez-Moreno, Carlos, and Kushner-Davalos, Luis
- Published
- 2016
- Full Text
- View/download PDF
3. Effectiveness of a multidimensional approach for prevention of ventilator-associated pneumonia in 11 adult intensive care units from 10 cities of Turkey: findings of the International Nosocomial Infection Control Consortium (INICC)
- Author
-
Leblebicioglu, H., Yalcin, A. N., Rosenthal, V. D., Koksal, I., Sirmatel, F., Unal, S., Turgut, H., Ozdemir, D., Ersoz, G., Uzun, C., Ulusoy, S., Esen, S., Ulger, F., Dilek, A., Yilmaz, H., Turhan, O., Gunay, N., Gumus, E., Dursun, O., Yýlmaz, G., Kaya, S., Ulusoy, H., Cengiz, M., Yilmaz, L., Yildirim, G., Topeli, A., Sacar, S., Sungurtekin, H., Uğurcan, D., Geyik, M. F., Şahin, A., Erdogan, S., Kaya, A., Kuyucu, N., Arda, B., and Bacakoglu, F.
- Published
- 2013
- Full Text
- View/download PDF
4. An epidemic form of AEP
- Author
-
Tomac, N., Kuyucu, N., Tezic, T., Duru, F., Karademir, S., and Gurer, Y.
- Published
- 2002
5. Tuberculin responses in children with allergic diseases
- Author
-
Ozmen, S., Tomac, N., Uysal, A., Arslan, Z., Kuyucu, N., and Yoney, A.
- Published
- 2002
6. An outbreak of Aseptic Meningitis due to echovirus type 30 in two cities of Turkey
- Author
-
Ozkaya, E., Hizel, K., Uysal, G., Akman, S., Terzioglu, S., and Kuyucu, N.
- Published
- 2002
7. Anterior laryngofissure approach in type III laryngotracheal cleft: a case report
- Author
-
Arslankoylu, A.E., Unal, M., Kuyucu, N., and Ismi, O.
- Subjects
Male ,Laryngotracheal cleft ,Laryngofissure ,Infant ,Laryngeal cleft ,Congenital Abnormalities ,Otorhinolaryngologic Surgical Procedures ,Trachea ,Fatal Outcome ,Humans ,Abnormalities, Multiple ,Larynx ,Mortality ,Case Series and Reports - Abstract
Laryngeal and laryngotracheal clefts are rare congenital malformations of the laryngobronchial tree. Their symptoms vary from mild cough to life threatening pulmonary aspiration and cyanosis. Type I and II clefts can be observed without surgical intervention, whereas type III and IV clefts usually require an anterior or lateral cervical approach. We present a case of type III laryngotracheal cleft seen in a 3-monthold male infant who died during revision surgery after an anterior laryngofissure approach. We discuss the difficulties in diagnosis, management and importance of anaesthesia for these rare anomalies in light of the current literature.I cleft laringei e laringotracheali sono rare malformazioni congenite dell’albero laringo-tracheo-bronchiale. La sintomatologia associata va dalla blanda tosse all’aspirazione e alla cianosi. I cleft di tipo I e II possono essere tenuti sotto osservazione senza intervenire chirurgicamente, mentre i tipi III e IV richiedono un approccio chirurgico anteriore o laterocervicale. Presentiamo il caso di un neonato di 3 mesi affetto da cleft laringotracheale di tipo III, deceduto in corso di revisione chirurgica dopo un approccio in laringofissura anteriore. Nel presente lavoro discutiamo, alla luce della letteratura, le difficoltà diagnostiche, le modalità di trattamento e le tecniche anestesiologiche relative a questa rara patologia.
- Published
- 2016
8. Antibody response to measles vaccination in Turkish children
- Author
-
Kuyucu, N., Dogru, Ü., and Akar, N.
- Published
- 1996
- Full Text
- View/download PDF
9. Disseminated pyomyositis with high creatine phosphokinase levels
- Author
-
KUYUCU, N, DOGRU, Ü, and UYSAL, G
- Published
- 1997
10. Congenital insensitivity to pain with anhidrosis: report of a 68-day-old case
- Author
-
Sipahi, T., Okumuş, N., Şahin, F., Kuyucu, N., Tan, E., and Gürer, Y.
- Published
- 1999
- Full Text
- View/download PDF
11. Seroprevalence of hepatitis B infection in Turkish children
- Author
-
Kuyucu, N., Dökmen, A., Yöney, A., and Teziç, T.
- Published
- 1998
- Full Text
- View/download PDF
12. Surgical site infection rates in 16 cities in Turkey: findings of the International Nosocomial Infection Control Consortium (INICC)
- Author
-
Leblebicioglu H, Erben N, Rosenthal VD, Sener A, Uzun C, Senol G, Ersoz G, Demirdal T, Duygu F, Willke A, Sirmatel F, Oztoprak N, Koksal I, Oncul O, Gurbuz Y, Güçlü E, Turgut H, Yalcin AN, Ozdemir D, Kendirli T, Aslan T, Esen S, Ulger F, Dilek A, Yilmaz H, Sunbul M, Ozgunes I, Usluer G, Otkun M, Kaya A, Kuyucu N, Kaya Z, Meric M, Azak E, Yýlmaz G, Kaya S, Ulusoy H, Haznedaroglu T, Gorenek L, Acar A, Tutuncu E, Karabay O, Kaya G, Sacar S, Sungurtekin H, Uğurcan D, Turhan O, Gumus E, and Dursu
- Subjects
Cities ,Cohort Studies ,Hospitals ,Humans ,Prevalence ,Prospective Studies ,Surgical Wound Infection/*epidemiology ,Turkey/epidemiology - Abstract
BACKGROUND: Surgical site infections (SSIs) are a threat to patient safety; however, there were no available data on SSI rates stratified by surgical procedure (SP) in Turkey. METHODS: Between January 2005 and December 2011, a cohort prospective surveillance study on SSIs was conducted by the International Nosocomial Infection Control Consortium (INICC) in 20 hospitals in 16 Turkish cities. Data from hospitalized patients were registered using the Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN) methods and definitions for SSIs. Surgical procedures (SPs) were classified into 22 types according to International Classification of Diseases, Ninth Revision criteria. RESULTS: We recorded 1879 SSIs, associated with 41,563 SPs (4.3%; 95% confidence interval, 4.3-4.7). Among the results, the SSI rate per type of SP compared with rates reported by the INICC and CDC NHSN were 11.9% for ventricular shunt (vs 12.9% vs 5.6%); 5.3% for craniotomy (vs 4.4% vs 2.6%); 4.9% for coronary bypass with chest and donor incision (vs 4.5 vs 2.9); 3.5% for hip prosthesis (vs 2.6% vs 1.3%), and 3.0% for cesarean section (vs 0.7% vs 1.8%). CONCLUSIONS: In most of the 22 types of SP analyzed, our SSI rates were higher than the CDC NHSN rates and similar to the INICC rates. This study advances the knowledge of SSI epidemiology in Turkey, allowing the implementation of targeted interventions.
- Published
- 2015
13. International Nosocomial Infection Control Consortium (INICC)
- Author
-
Leblebicioglu, H, Erben, N, Rosenthal, VD, Sener, A, Uzun, C, Senol, G, Ersoz, G, Demirdal, T, Duygu, F, Willke, A, Sirmatel, F, Oztoprak, N, Koksal, I, Oncul, O, Gurbuz, Y, Guclu, E, Turgut, H, Yalcin, AN, Ozdemir, D, Kendirli, T, Aslan, T, Esen, S, Ulger, F, Dilek, A, Yilmaz, H, Sunbul, M, Ozgunes, I, Usluer, G, Otkun, M, Kaya, A, Kuyucu, N, Kaya, Z, Meric, M, Azak, E, Yylmaz, G, Kaya, S, Ulusoy, H, Haznedaroglu, T, Gorenek, L, Acar, A, Tutuncu, E, Karabay, O, Kaya, G, Sacar, S, Sungurtekin, H, Ugurcan, D, Turhan, O, Gumus, E, Dursun, O, Geyik, MF, Sahin, A, Erdogan, S, Ince, E, Karbuz, A, Ciftci, E, Tasyapar, N, and Gunes, M
- Subjects
infection ,Surgical wound infection ,Developing countries ,Hospital infection ,Nosocomial infection ,Health care-associated - Abstract
Background: Surgical site infections (SSIs) are a threat to patient safety; however, there were no available data on SSI rates stratified by surgical procedure (SP) in Turkey. Methods: Between January 2005 and December 2011, a cohort prospective surveillance study on SSIs was conducted by the International Nosocomial Infection Control Consortium (INICC) in 20 hospitals in 16 Turkish cities. Data from hospitalized patients were registered using the Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN) methods and definitions for SSIs. Surgical procedures (SPs) were classified into 22 types according to International Classification of Diseases, Ninth Revision criteria. Results: We recorded 1879 SSIs, associated with 41,563 SPs (4.3%; 95% confidence interval, 4.3-4.7). Among the results, the SSI rate per type of SP compared with rates reported by the INICC and CDC NHSN were 11.9% for ventricular shunt (vs 12.9% vs 5.6%); 5.3% for craniotomy (vs 4.4% vs 2.6%); 4.9% for coronary bypass with chest and donor incision (vs 4.5 vs 2.9); 3.5% for hip prosthesis (vs 2.6% vs 1.3%), and 3.0% for cesarean section (vs 0.7% vs 1.8%). Conclusions: In most of the 22 types of SP analyzed, our SSI rates were higher than the CDC NHSN rates and similar to the INICC rates. This study advances the knowledge of SSI epidemiology in Turkey, allowing the implementation of targeted interventions. Copyright (C) 2015 by the Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
- Published
- 2015
14. Surgical site infection rates in 16 cities in Turkey: findings of the International Nosocomial Infection Control Consortium (INICC)
- Author
-
Leblebicioglu, H., Erben, N., Rosenthal, V.D., Sener, A., Uzun, C., Senol, G., Ersoz, G., Demirdal, T., Duygu, F., Willke, A., Sirmatel, F., Oztoprak, N., Koksal, I., Oncul, O., Gurbuz, Y., Güçlü, E., Turgut, H., Yalcin, A.N., Ozdemir, D., Kendirli, T., Aslan, T., Esen, S., Ulger, F., Dilek, A., Yilmaz, H., Sunbul, M., Ozgunes, I., Usluer, G., Otkun, M., Kaya, A., Kuyucu, N., Kaya, Z., Meric, M., Azak, E., Yýlmaz, G., Kaya, S., Ulusoy, H., Haznedaroglu, T., Gorenek, L., Acar, A., Tutuncu, E., Karabay, O., Kaya, G., Sacar, S., Sungurtekin, H., Uğurcan, Doğaç, Turhan, O., Gumus, E., Dursun, O., Geyik, M.F., Şahin, A., Erdogan, S., Ince, E., Karbuz, A., Çiftçi, E., Taşyapar, N., and Güneş, M.
- Subjects
Turkey ,Surgical wound infection ,Health careeassociated infection ,prevalence ,infection rate ,surgical infection ,Article ,Turkey (republic) ,Developing countries ,Cohort Studies ,hip prosthesis ,Nosocomial infection ,coronary artery bypass graft ,Humans ,Hospital infection ,human ,Prospective Studies ,hospital ,Cities ,cesarean section ,craniotomy ,clinical trial ,cohort analysis ,shunting ,Hospitals ,hospital patient ,multicenter study ,city ,prospective study - Abstract
Background: Surgical site infections (SSIs) are a threat to patient safety; however, there were no available data on SSI rates stratified by surgical procedure (SP) in Turkey. Methods: Between January 2005 and December 2011, a cohort prospective surveillance study on SSIs was conducted by the International Nosocomial Infection Control Consortium (INICC) in 20 hospitals in 16 Turkish cities. Data from hospitalized patients were registered using the Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN) methods and definitions for SSIs. Surgical procedures (SPs) were classified into 22 types according to International Classification of Diseases, Ninth Revision criteria. Results: We recorded 1879 SSIs, associated with 41,563 SPs (4.3%; 95% confidence interval, 4.3-4.7). Among the results, the SSI rate per type of SP compared with rates reported by the INICC and CDC NHSN were 11.9% for ventricular shunt (vs 12.9% vs 5.6%); 5.3% for craniotomy (vs 4.4% vs 2.6%); 4.9% for coronary bypass with chest and donor incision (vs 4.5 vs 2.9); 3.5% for hip prosthesis (vs 2.6% vs 1.3%), and 3.0% for cesarean section (vs 0.7% vs 1.8%). Conclusions: In most of the 22 types of SP analyzed, our SSI rates were higher than the CDC NHSN rates and similar to the INICC rates. This study advances the knowledge of SSI epidemiology in Turkey, allowing the implementation of targeted interventions. Copyright © 2015 by the Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
- Published
- 2015
15. report on device-associated infection rates in 19 cities of Turkey, data
- Author
-
Leblebicioglu, H, Erben, N, Rosenthal, VD, Atasay, B, Erbay, A, Unal, S, Senol, G, Willke, A, Ozgultekin, A, Altin, N, Bakir, M, Oncul, O, Ersoz, G, Ozdemir, D, Yalcin, AN, Ozdemir, H, Yildizdas, D, Koksal, I, Aygun, C, Sirmatel, F, Sener, A, Tuna, N, Akan, OA, Turgut, H, Demiroz, AP, Kendirli, T, Alp, E, Uzun, C, Ulusoy, S, Arman, D, Ozgunes, I, Usluer, G, Kilic, A, Arsan, S, Cabadak, H, Sen, S, Gelebek, Y, Zengin, H, Topeli, A, Alper, Y, Meric, M, Azak, E, Inan, A, Turan, G, Haznedaroglu, T, Gorenek, L, Acar, A, Cesur, S, Engin, A, Kaya, A, Kuyucu, N, Geyik, MF, Aydin, OC, Erdogan, NS, Turhan, O, Gunay, N, Gumus, E, Dursun, O, Esen, S, Ulger, F, Dilek, A, Yilmaz, H, Sunbul, M, Gokmen, Z, Ozdemir, SI, Horoz, OO, Yylmaz, G, Kaya, S, Ulusoy, H, Kucukoduk, S, Ustun, C, Baysal, AI, Otkun, M, Tulunay, M, Oral, M, Unal, N, Cengiz, M, Yilmaz, L, Sacar, S, Sungurtekin, H, Ugurcan, D, Yetkin, MA, Bulut, C, Erdinc, FS, Hatipoglu, CA, Ince, E, Ciftci, E, Odek, C, Yaman, A, Karbuz, A, Aldemir, B, Kilic, AU, Arda, B, Bacakoglu, F, and Hizel, K
- Subjects
infection ,Urinary tract infection ,Network ,Ventilator-associated pneumonia ,Catheter-associated urinary tract ,health care facilities, manpower, and services ,Central line-associated bloodstream infections ,Bloodstream ,VELOPING-COUNTRIES ,MULTIDIMENSIONAL APPROACH ,STRATEGY ,IMPACT ,INICC ,International Nosocomial Infection Consortium ,Turkey ,Device-associated infection ,Antibiotic resistance ,Hospital infection ,Nosocomial infection ,Healthcare-associated - Abstract
Background: Device-associated healthcare-acquired infections (DA-HAI) pose a threat to patient safety, particularly in the intensive care unit (ICU). We report the results of the International Infection Control Consortium (INICC) study conducted in Turkey from August 2003 through October 2012. Methods: A DA-HAI surveillance study in 63 adult, paediatric ICUs and neonatal ICUs (NICUs) from 29 hospitals, in 19 cities using the methods and definitions of the U.S. NHSN and INICC methods. Results: We collected prospective data from 94,498 ICU patients for 647,316 bed days. Pooled DA-HAI rates for adult and paediatric ICUs were 11.1 central line-associated bloodstream infections (CLABSIs) per 1000 central line (CL)-days, 21.4 ventilator-associated pneumonias (VAPs) per 1000 mechanical ventilator (MV)-days and 7.5 catheter-associated urinary tract infections (CAUTIs) per 1000 urinary catheter-days. Pooled DA-HAI rates for NICUs were 30 CLABSIs per 1000 CL-days, and 15.8 VAPs per 1000 MV-days. Extra length of stay (LOS) in adult and paediatric ICUs was 19.4 for CLABSI, 8.7 for VAP and 10.1 for CAUTI. Extra LOS in NICUs was 13.1 for patients with CLABSI and 16.2 for patients with VAP. Extra crude mortality was 12% for CLABSI, 19.4% for VAP and 10.5% for CAUTI in ICUs, and 15.4% for CLABSI and 10.5% for VAP in NICUs. Pooled device use (DU) ratios for adult and paediatric ICUs were 0.54 for MV, 0.65 for CL and 0.88 for UC, and 0.12 for MV, and 0.09 for CL in NICUs. The CLABSI rate was 8.5 per 1,000 CL days in the Medical Surgical ICUs included in this study, which is higher than the INICC report rate of 4.9, and more than eight times higher than the NHSN rate of 0.9. Similarly, the VAP and CAUTI rates were higher compared with U. S. NHSN (22.3 vs. 1.1 for VAP; 7.9 vs. 1.2 for CAUTI) and with the INICC report (22.3 vs. 16.5 in VAP; 7.9 vs. 5.3 in CAUTI). Conclusions: DA-HAI rates and DU ratios in our ICUs were higher than those reported in the INICC global report and in the US NHSN report.
- Published
- 2014
16. International Nosocomial Infection Control Consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003-2012
- Author
-
Leblebicioglu, H., Erben, N., Rosenthal, V.D., Atasay, B., Erbay, A., Unal, S., Senol, G., Willke, A., Özgültekin, A., Altin, N., Bakir, M., Oncul, O., Ersöz, G., Ozdemir, D., Yalcin, A.N., Özdemir, H., Yıldızdaş, D., Koksal, I., Aygun, C., Sirmatel, F., Sener, A., Tuna, N., Akan, Ö.A., Turgut, H., Demiroz, A.P., Kendirli, T., Alp, E., Uzun, C., Ulusoy, S., Arman, D., Ozgunes, I., Usluer, G., Kiliç, A., Arsan, S., Cabadak, H., Sen, S., Gelebek, Y., Zengin, H., Topeli, A., Alper, Y., Meric, M., Azak, E., İnan, A., Turan, G., Haznedaroglu, T., Gorenek, L., Acar, A., Cesur, S., Engin, A., Kaya, A., Kuyucu, N., Geyik, M.F., Aydın, Ö.Ç., Erdogan, N.S., Turhan, O., Gunay, N., Gumus, E., Dursun, O., Esen, S., Ulger, F., Dilek, A., Yilmaz, H., Sunbul, M., Gökmen, Z., Özdemir, S.İ., Horoz, O.O., Yýlmaz, G., Kaya, S., Ulusoy, H., Küçüködük, S., Ustun, C., Otkun, M., Tulunay, M., Oral, M., Ünal, N., Cengiz, M., Yilmaz, L., Sacar, S., Sungurtekin, H., Uğurcan, D., Yetkin, M.A., Bulut, C., Erdinc, F.S., Hatipoglu, C.A., İnce, E., Çiftçi, E., Ödek, Ç., Yaman, A., Karbuz, A., Aldemir, B., Kılıc, A.U., Arda, B., Bacakoglu, F., and Hizel, K.
- Subjects
Male ,Turkey ,healthcare associated infection ,Antibiotic resistance ,health care facilities, manpower, and services ,central venous catheter ,Network ,intensive care unit ,preschool child ,Turkey (republic) ,Cohort Studies ,Nosocomial infection ,newborn ,device infection ,Prevalence ,Prospective Studies ,Child ,intensive care ,catheter infection ,Urinary tract infection ,Cross Infection ,adult ,Pneumonia, Ventilator-Associated ,INICC ,cohort analysis ,infection control ,Device-associated infection ,female ,Equipment and Supplies ,Child, Preschool ,disease surveillance ,devices ,prospective study ,Adolescent ,Catheter-associated urinary tract infection ,infection rate ,Bloodstream infection ,Article ,critically ill patient ,length of stay ,Ventilator-associated pneumonia ,Humans ,Hospital infection ,human ,Healthcare-associated infection ,urinary catheter ,Infant, Newborn ,Infant ,International Nosocomial Infection Consortium ,mechanical ventilator ,major clinical study ,mortality ,Catheter-Related Infections ,ventilator associated pneumonia ,Central line-associated bloodstream infections - Abstract
Background: Device-associated healthcare-acquired infections (DA-HAI) pose a threat to patient safety, particularly in the intensive care unit (ICU). We report the results of the International Infection Control Consortium (INICC) study conducted in Turkey from August 2003 through October 2012. Methods: A DA-HAI surveillance study in 63 adult, paediatric ICUs and neonatal ICUs (NICUs) from 29 hospitals, in 19 cities using the methods and definitions of the U.S. NHSN and INICC methods. Results: We collected prospective data from 94,498 ICU patients for 647,316 bed days. Pooled DA-HAI rates for adult and paediatric ICUs were 11.1 central line-associated bloodstream infections (CLABSIs) per 1000 central line (CL)-days, 21.4 ventilator-associated pneumonias (VAPs) per 1000 mechanical ventilator (MV)-days and 7.5 catheter-associated urinary tract infections (CAUTIs) per 1000 urinary catheter-days. Pooled DA-HAI rates for NICUs were 30 CLABSIs per 1000 CL-days, and 15.8 VAPs per 1000 MV-days. Extra length of stay (LOS) in adult and paediatric ICUs was 19.4 for CLABSI, 8.7 for VAP and 10.1 for CAUTI. Extra LOS in NICUs was 13.1 for patients with CLABSI and 16.2 for patients with VAP. Extra crude mortality was 12% for CLABSI, 19.4% for VAP and 10.5% for CAUTI in ICUs, and 15.4% for CLABSI and 10.5% for VAP in NICUs. Pooled device use (DU) ratios for adult and paediatric ICUs were 0.54 for MV, 0.65 for CL and 0.88 for UC, and 0.12 for MV, and 0.09 for CL in NICUs. The CLABSI rate was 8.5 per 1,000 CL days in the Medical Surgical ICUs included in this study, which is higher than the INICC report rate of 4.9, and more than eight times higher than the NHSN rate of 0.9. Similarly, the VAP and CAUTI rates were higher compared with U.S. NHSN (22.3 vs. 1.1 for VAP; 7.9 vs. 1.2 for CAUTI) and with the INICC report (22.3 vs. 16.5 in VAP; 7.9 vs. 5.3 in CAUTI). Conclusions: DA-HAI rates and DU ratios in our ICUs were higher than those reported in the INICC global report and in the US NHSN report. © 2014 Leblebicioglu et al.
- Published
- 2014
17. ACTA OTORHINOLARYNGOLOGICA ITALICA
- Author
-
Arslankoylu, A.E., primary, Unal, M., additional, Kuyucu, N., additional, and Ismi, O., additional
- Published
- 2016
- Full Text
- View/download PDF
18. Control Consortium findings (INICC)
- Author
-
Leblebicioglu, H, Ersoz, G, Rosenthal, VD, Nevzat-Yalcin, A, Akan, OA, Sirmatel, F, Turgut, H, Ozdemir, D, Alp, E, Uzun, C, Ulusoy, S, Esen, S, Ulger, F, Dilek, A, Yilmaz, H, Kaya, A, Kuyucu, N, Turhan, O, Gunay, N, Gumus, E, Dursun, O, Tulunay, M, Oral, M, Unal, N, Cengiz, M, Yilmaz, L, Sacar, S, Sungurtekin, H, Ugurcan, D, Geyik, MF, Sahin, A, Erdogan, S, Aygen, B, Arda, B, and Bacakoglu, F
- Subjects
infections ,Urinary catheter ,Developing countries ,Limited resources ,Hospital infection ,Nosocomial infection ,Health care-acquired ,Critical care ,Incidence density ,Bundle ,Hand hygiene ,Handwashing ,infection ,Device-associated infection ,Catheter-related urinary tract ,countries ,Low-income countries ,Emerging countries ,Surveillance - Abstract
Background: We evaluate the effectiveness of a multidimensional infection control approach for the reduction of catheter-associated urinary tract infections (CAUTIs) in 13 intensive care units (ICUs) in 10 hospital members of the International Nosocomial Infection Control Consortium (INICC) from 10 cities of Turkey. Methods: A before-after prospective active surveillance study was used to determine rates of CAUTI. The study was divided into baseline (phase 1) and intervention (phase 2). In phase 1, surveillance was performed applying the definitions of the Centers for Disease Control and Prevention/National Healthcare Safety Network. In phase 2, we implemented a multidimensional approach that included bundle of infection control interventions, education, surveillance and feedback on CAUTI rates, process surveillance, and performance feedback. We used random effects Poisson regression to account for clustering of CAUTI rates across time periods. Results: The study included 4,231 patients, hospitalized in 13 ICUs, in 10 hospitals, in 10 cities, during 49,644 patient-days. We recorded a total of 41,871 urinary catheter (UC)-days: 5,080 in phase 1 and 36,791 in phase 2. During phase 1, the rate of CAUTI was 10.63 per 1,000 UC-days and was significantly decreased by 47% in phase 2 to 5.65 per 1,000 UC-days (relative risk, 0.53; 95% confidence interval: 0.4-0.7; P value = .0001). Conclusion: Our multidimensional approach was associated with a significant reduction in the rates of CAUTI in Turkey. Copyright (C) 2013 by the Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
- Published
- 2013
19. International nosocomial infection control consortium (INICC) report, data summary of 36 countries, for 2004-2009
- Author
-
Rosenthal, V.D., Bijie, H., Maki, D.G., Mehta, Y., Apisarnthanarak, A., Medeiros, E.A., Leblebicioglu, H., Fisher, D., Álvarez-Moreno, C., Khader, I.A., Martínez, M.D.R.G., Cuellar, L.E., Navoa-Ng, J.A., Abouqal, R., Garcell, H.G., Mitrev, Z., García, M.C.P., Hamdi, A., Dueñas, L., Cancel, E., Gurskis, V., Rasslan, O., Ahmed, A., Kanj, S.S., Ugalde, O.C., Mapp, T., Raka, L., Meng, C.Y., Thu, L.T.A., Ghazal, S., Gikas, A., Narváez, L.P., Mejía, N., Hadjieva, N., Elanbya, M.O.G., Siritt, M.E.G., Jayatilleke, K., Frías, M.L., Churruarín, G., Sztokhamer, D., Flynn, L.P., Rausch, D., Spagnolo, A., Santero, B., Soroka, L.C., For-Ciniti, S., Blasco, M., Lezcano, C.B., Lastra, C.E., Bedoya, M.Á.F., Costamagna, A., Dheza, G.R., Ávalos, J., Álvarez, M., Bench-Etrit, G., Bonaventura, C., Caridi, M.Á., Messina, A., Ricci, B., Viegas, M., Di Núbila, B.M.A., Lan-Zetta, D., Fernández, L.J., Rossetti, M.A., Romani, A., Migazzi, C., Barolin, C., Martínez, E., Bernan, M.L., Bay, M.R., Diaz, F.R., Dominguez, C.B., Coria, G.E., Martinelli, M.E., Grinberg, G., Ferreira, I.B., Cechinel, R.B., Zanandrea, B.B., Rohnkohl, C., Regalin, M., Spessatto, J.L., Pasini, R.S., Ferla, S., Salomao, R., da Silva, M.Â.M., de Jesus Silva, C.H., Vilins, M., Blecher, S., Angelieri, D.B., Kuchenbecker, R.S., Pires, M.R., Santos, R.P., Kuplich, N.M., Siliprandi, E.M.O., Do-Amaral, A.P., Silva, C.P.R., Biancalana, M.L.N., Sánchez, T.E.G., Valente, R., Apolinário, D., Freitas, L.F.B., Dos Santos, M.C.I., Lopes, J.M.M., Valadares, P.C.P., Batista, J.P., Campos, M.A.-E.S., Moretti, M.L., Cardoso, L.G., Trabaos, A., Martins, I.S., Santos, P.T.D., Pinhejro, D.O.B.P., Abreu, J.S.D., Richtmann, R., Rodríguez, T., Baltieri, S.R., Moreira, M., Stadtlober, G.F., Cavaglieri, A.G., Karadimovm, D., Velinova, V., Qin, J.A., Juan, H., Fang, H.C., Gao, X., Lili, T., Yao, S., Hungmei, W., Bin, C., Ruisheng, L., Yang, Y., Yeguxiang, Ziqin, X., Mei, W.H., Chun, G.S., Yang, X., Gan, A., Zhang, A., Luo, J., Zhao, A., Li, F., Liu, B., Gao, M., Zhao, B., Wei, L., Wang, C., Fang, L., Yi, C., Xie, X., Ling, F., Wu, Y., Xu, F., Feng, F., Weng, F., Dong, G.-H., Ye, G., Yang, W., Yu, H., Yang, H.-I., Yan, H., Mao, A., Zhou, H., Chen, W., Gong, H., Tan, H., Liu, Y., Wu, H., Tang, D., Hao, J., Zhang, H., Wang, J., Qiu, Y., Yu, J., Gu, X., Jiang, J., Zhang, M., Miu, J., Zhao, W., Shi, J., Li, L., Duo, K., Cai, L., Liu, L., Hua, L., Shao, Q., An, Y., Lu, Q., Li, G., Sun, R., Zhang, W., Tao, Z., Wang, W., Shen, Y., Fan, W., Chen, H., Yao, X., Wen, H., Xiong, X., Xu, H., Liu, X., Huang, M., Wang, X., Shao, G., Yuan, Y., Cao, Y., Chen, Y., Chen, X., Gu, Y., Zhu, L., Huang, Y., Wang, M., Wang, Y., Mao, Y., Cheng, Y., Zhao, C., Sun, Y., Zhu, B., Cai, M., Zhang, Y., Xue, M., Zhou, Y., Zhang, R., Du, Y., Li, D., Ni, Y., Zhang, L., Zhong, Z., Zhu, G., Yu, Z., Cao, M., Song, Z., Xu, J., Tong, Z., Gu, P., Agudelo, J.G., Sussmann, O., Mojica, B.E., Rojas, C., Beltran, H., Paez, J., Gómez, W.V., Dajud, L., Mendoza, M., Arrieta, P., Osorio, L., Olarte, N., Valderrama, A., Muñoz, H.J., Guzmán, N.B., Ferrer, M.R., Villa, G.S., Guzmán, A.L., Linares, C., Cortés, L.M., Campo, L.F.R., Menco, A., Calderón, M.E.R., Parada, D.E.C., Fernandez, A.M.P., Martínez, I.F.P., Saleg, P.A.M., Vega, Y.L., Luengas, E.L., Ramos, C.R., Hernández, H.T., Gomez, D.Y., Gomez, B.M.V., Ruiz, M.G., Millán, J.C.T., López, M.U.T., Parada, E.C., Rochel, A.E.M., Hidalgo, R.F., Calzada, J.M.A., Muñoz, G., Argüello, A.R., Chinchilla, A.S., Fuentes, C.G., Pérez, C.M., Pino, O.R., González, O.D., González, D.F., de Wang, C.M.R., Severino, R., Tolari, G., Delgado, M., Vélez, J.W., Zapata, M.A.C., Valle, M.J., Guayasamín, S., Seliem, Z.S., El Kholy, A.A., Abdel-Aziz, D., Sabour, M.A.E., Kalil, M., Saeed, A., Gafarey, M.E., Fouad, L., Muhamed, T., Saeed, H., Casares, A.C.B., Machuca, L.J., Chaniotaki, K., Tsioutis, C., Bampalis, D., Gopinath, R., Ravindra, N., Karlekar, A., Sood, S., Verma, N., Sen, N., Subramani, K., Raj, J.P., Mathur, P., Kumar, S., Sahu, S., Govil, D., Jaggi, N., Bhatnagar, S., Myatra, S.N., Divatia, Kelkar, R., Biswas, S., Raut, S., Sampat, S., Kumar, R., Todi, S.K., Bhakta, A., Bhattacharjee, M., Ramachandran, B., Chakravarthy, M., Gokul, B.N., Sukanya, R., Pushparaj, L., Singh, S., Radhakrishnan, K., Udwadia, F.E., Ansari, R., Poojary, A., Koppikar, G., Bhandarkar, L., Jadhav, S., Dwivedy, A., Shetty, S., Binu, S., Pawar, M., Gupta, A., Saini, N., Kothari, V., Singhal, T., Shah, S., Rodrigues, C., Hegd, A., Kapadia, F., Mehta, P., Surase, P., Narayanan, S., Munshi, N., Padbidri, V., Dawhale, R., Jacobs, S.M., Khuri-Bulos, N., Mahafzah, A., Baftiu, N., Spahija, G., Zahreddine, N., Alamuddin, L., Kanafani, Z., Dagys, A., Kondratas, T., Kevalas, R., Anguseva, T., Ampova, V., Guroska, S.T.-C., Manikavasagam, J., Tan, L.H., Kaur, K., Assadian, O., Wolfram, R., Kaur, P., Oropeza, M.S., Ruiz, A.A., Campuzano, R., Brito, J.M., Serrato, I.P., López, M.S., Gómez, A.C., Morales, J.R., Rodríguez, J.E.V., Gallo, J.H.P., Almazán, F.A., Miramontes, G.I., Vázquez Olivas, M.D.R., Chávez, A.S., Espinoza, Y.A., Gallegos, L.A., González, D.J.S., Rochín, A.M., Félix, M.J.S., Peña, R.D., Gómez, A.B.Z., Gutiérrez, C.A.E., Novales, M.G.M., Herver, M.D.J., Gaytan, J.A., Olmeda, J.A.G., Martínez-Marroquín, M.Y., Hernández, A., García, E.O., Cervantes, R.V., Arteaga-Troncoso, G., Guerra Infante, F.M., Méndez, I.M., Burguete, M.C.C., Barkat, A., Bouazzaoui, N.L., Meryem, K., Madani, N., Zeggwagh, A.A., Abidi, K., Dendane, T., Khan, S.G., Ali, F., Hussain, Y., Butt, F., Fakir, A., Mahmood, S.F., Jamil, B., Memon, B.A., Bhutto, G.H., Alfaro, F.G., Alvarado, C., León, L.M.D., Navarro, R., Moreno, J.L., Cerrad, R., Sabogal, A.C., Goicochea, I.P., Sanchez, A.A., Alva, G.R., Ventura, J.G., Aguilar, M.R., Plasencia, N.S., Maldonado, E.F., Espichan, M.J.M., Echenique, L., Rosales, R., Bravo, L.I.C., Cáceres, M.L., Espinoza, T.A., López, F.S., Saldarriaga, M.E.C., Morvelí, E.U.V., Barriga, H., Villacorta, M.S., Barrios, S.C., Zegarra, S.L.T., Astete, N.S., Guevara, F.C., Mendoza, C.B., Ramírez, A.V., Pastrana, J.S., Wong, F.M.R., Ángeles, C.S., Tavera, Z.D., Ramirez, E., Vergara, C.E.L.H., Mendoza, L., Sosa, G.B., Chávez, C.M., Berba, R., Genuino, G.A.S., Consunji, R.J., Mantaring, J.B.V., III, Villanueva, V.D., Tolentino, M.C.V., Galapia, Y.A., Tambyah, P.A., Hakawi, A., Kaluarachchi, N.N., Samaraweera, G.A.-R., Sid Ahmed Ali, I.M., Satti, A.A., Jamulitrat, S., Thamlikitkul, V., Ben-Jaballah, N., Ammar, K., Öztürk, R., Dikmen, Y., Aygún, G., Ulusoy, S., Arda, B., Bacakoglu, F., Sardan, Y.C., Yildirim, G., Topeli, A., Akan, Ö.A., Tulunay, M., Oral, M., Ünal, N., Alp, E., Aygen, B., Sirmatel, F., Cengiz, M., Yilmaz, L., Özgültekin, A., Turan, G.-D., Akgün, N., Ozdemir, D., Guclu, E., Erdogan, S., Erben, N., Ozgunes, I., Usluer, G., Aygun, C., Küçüködük, S., Arman, D., Hizel, K., Uzun, C., Turgut, Hüseyin, Saçar, Suzan, Sungurtekin, Hülya, Uğurcan, Doğaç, Koksal, I., Yýlmaz, G., Kaya, S., Ulusoy, H., Ersoz, G., Kaya, A., Kuyucu, N., Esen, S., Ulger, F., Dilek, A., Yalcin, A.N., Turhan, O., Keskin, S., Gumus, E., Dursun, O., Kendirli, T., Ince, E., Cliftci, E., Özdemir, H., Demiroz, A.P., Yetkin, M.A., Bulut, C., Erdinc, F.S., Hatipoglu, C.A., Erbay, A., Willke, A., Meric, M., Azak, E., Oncul, O., Haznedaroglu, T., Gorenek, L., Acar, A., Silvera, E., Techera, S., Frachia, A., Algorta, G., Gil de Añez, Z.D., Bravo, L.M., Orozco, N., Mejías, E., Trang, D.T.V., Nga, T.T.K., and Zruong, P.H.
- Subjects
meticillin ,Staphylococcus aureus ,Asia ,Antibiotic resistance ,Health care-associated infection ,Catheter-associated urinary tract infection ,Network ,bloodstream infection ,intensive care unit ,Developing countries ,South and Central America ,Nosocomial infection ,Escherichia coli ,Ventilator-associated pneumonia ,Hospital infection ,human ,ceftazidime ,catheter infection ,Urinary tract infection ,nonhuman ,bacterium isolate ,article ,developing country ,infection control ,mortality ,Device-associated infection ,Low-income countries ,hospital bed ,Europe ,Klebsiella pneumoniae ,Central line-associated bloodstream infection ,Africa ,Pseudomonas aeruginosa ,Limited-resources countries ,disease surveillance ,ventilator associated pneumonia ,hospitalization ,prospective study - Abstract
The results of a surveillance study conducted by the International Nosocomial Infection Control Consortium (INICC) from January 2004 through December 2009 in 422 intensive care units (ICUs) of 36 countries in Latin America, Asia, Africa, and Europe are reported. During the 6-year study period, using Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN; formerly the National Nosocomial Infection Surveillance system [NNIS]) definitions for device-associated health care-associated infections, we gathered prospective data from 313,008 patients hospitalized in the consortium's ICUs for an aggregate of 2,194,897 ICU bed-days. Despite the fact that the use of devices in the developing countries' ICUs was remarkably similar to that reported in US ICUs in the CDC's NHSN, rates of device-associated nosocomial infection were significantly higher in the ICUs of the INICC hospitals; the pooled rate of central line-associated bloodstream infection in the INICC ICUs of 6.8 per 1,000 central line-days was more than 3-fold higher than the 2.0 per 1,000 central line-days reported in comparable US ICUs. The overall rate of ventilator-associated pneumonia also was far higher (15.8 vs 3.3 per 1,000 ventilator-days), as was the rate of catheter-associated urinary tract infection (6.3 vs. 3.3 per 1,000 catheter-days). Notably, the frequencies of resistance of Pseudomonas aeruginosa isolates to imipenem (47.2% vs 23.0%), Klebsiella pneumoniae isolates to ceftazidime (76.3% vs 27.1%), Escherichia coli isolates to ceftazidime (66.7% vs 8.1%), Staphylococcus aureus isolates to methicillin (84.4% vs 56.8%), were also higher in the consortium's ICUs, and the crude unadjusted excess mortalities of device-related infections ranged from 7.3% (for catheter-associated urinary tract infection) to 15.2% (for ventilator-associated pneumonia). Copyright © 2012 by the Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
- Published
- 2012
20. Comparison of two different regimens of combined interferon-alpha 2a and lamivudine therapy in children with chronic hepatitis B infection
- Author
-
Ertekin, V, Yagci, RV, Bosnak, M, Girgin, N, Kuloglu, Z, Haspolat, K, Tanir, G, Ozkan, TB, Kosirga, E, Selimoglu, A, Dalgic, B, Dikici, B, Kalayci, AG, Kuyucu, N, Artan, R, Akman, SA, Doganci, T, Kansu, A, and Aydogdu, S
- Abstract
Aim: To evaluate the efficacy of two regimens of combined interferon-alpha 2a (IFN-alpha 2a) and lamivudine (3TC) therapy in childhood chronic hepatitis B.
- Published
- 2006
21. Comparison of two different regimens of combined interferon-?2a and lamivudine therapy in children with chronic hepatitis B infection
- Author
-
Kansu A., Doğanci T., Akman S.A., Artan R., Kuyucu N., Kalayci A.G., Yağci R.V., and Ondokuz Mayıs Üniversitesi
- Abstract
PubMed: 16640106 Aim: To evaluate the efficacy of two regimens of combined interferon-?2a (IFN-?2a) and lamivudine (3TC) therapy in childhood chronic hepatitis B. Methods: A total of 177 patients received IFN-?2a, 9 million units (MU)/m2 for 6 months. In group I (112 patients, 8.7±3.5 years), 3TC (4 mg/kg/day, max 100 mg) was started simultaneously with IFN-?2a, in group II (65 patients, 9.6±3.8 years) 3TC was started 2 months prior to IFN-?2a. 3TC was continued for 6 months after antiHBe seroconversion or stopped at 24 months in non-responders. Results: Baseline alanine aminotransferase (ALT) was 134.2±34.1 and 147.0±45.3; histological activity index (HAI) was 7.4±2.7 and 7.1±2.3; and HBV DNA levels were above 2,000 pg/ml in 76% and 66% of patients in groups I and II, respectively (P>0.005). Complete response was 55.3% and 27.6% in groups I and II, respectively (P0.05). Breakthrough occurred in 17.9% and 24.6%; breakthrough times were 15.9±4.6 and 14.1±5.1 months; and relapse rates were 6.8% and none in groups I and II, respectively (P>0.05, P>0.05, P>0.05). Responders had higher HAI (HAI>6) and higher pre-treatment ALT than non-responders. Conclusion: Simultaneous 3TC+IFN-?2a yields a higher response and earlier antiHBe seroconversion and viral clearance than consecutive combined therapy. Relapse rate is low. Predictors of response are high basal ALT and high HAI scores. 3TC can be administered for 24 months without any side effect and breakthrough rate is comparable with previous studies. © 2006 International Medical Press.
- Published
- 2006
22. Comparison of two different regimens of combined interferon-alpha 2a and lamivudine therapy in children with chronic hepatitis B infection
- Author
-
Kansu, A, Doganci, T, Akman, SA, Artan, R, Kuyucu, N, Kalayci, AG, Yagci, RV, and Ondokuz Mayıs Üniversitesi
- Abstract
dikici, bunyamin/0000-0001-7572-6525; Kuloglu, Zarife/0000-0001-9442-7790 WOS: 000236640500013 PubMed: 16640106 Aim: To evaluate the efficacy of two regimens of combined interferon-alpha 2a (IFN-alpha 2a) and lamivudine (3TC) therapy in childhood chronic hepatitis B. Methods: A total of 177 patients received IFN-alpha 2a, 9 million units (MU)/m(2) for 6 months. In group 1 (112 patients, 8.7 +/- 3.5 years), 3TC (4 mg/kg/day, max 100 mg) was started simultaneously with IFN-alpha 2a, in group 11 (65 patients, 9.6 +/- 3.8 years) 3TC was started 2 months prior to IFN-alpha 2a. 3TC was continued for 6 months after antiHBe seroconversion or stopped at 24 months in non-responders. Results: Baseline alanine aminotransferase (ALT) was 134.2 +/- 34.1 and 147.0 +/- 45.3; histological activity index (HAI) was 7.4 +/- 2.7 and 7.1 +/- 2.3; and HBV DNA levels were above 2,000 pg/ml in 76% and 66% of patients in groups I and 11, respectively (P > 0.005). Complete response was 55.3% and 27.6% in groups I and 11, respectively (P < 0.01). AntiHBe seroconversion was higher and earlier, and HBV DNA clearance was earlier in group I (P < 0.05). HBsAg clearance was 12.5% and 4.6% and antiHBs seroconversion was 9.8% and 6.2% in groups I and 11, respectively (P > 0.05). Breakthrough occurred in 17.9% and 24.6%; breakthrough times were 15.9 +/- 4.6 and 14.1 +/- 5.1 months; and relapse rates were 6.8% and none in groups I and 11, respectively (P > 0.05, P > 0.05, P > 0.05). Responders had higher HAI (HAI > 6) and higher pre-treatment ALT than non-responders. Conclusion: Simultaneous 3TC+IFN-alpha 2a yields a higher response and earlier antiHBe seroconversion and viral clearance than consecutive combined therapy. Relapse rate is low. Predictors of response are high basal ALT and high HAI scores. 3TC can be administered for 24 months without any side effect and breakthrough rate is comparable with previous studies.
- Published
- 2006
23. External morphology of eggs of Tipula (Lunatipula) decolor, Tipula (Lunatipula) dedecor, and Tipula (Acutipula) latifurca (Diptera : Tipulidae)
- Author
-
Suludere, Z, Kuyucu, N, Koc, H, and Candan, SELAMİ
- Subjects
embryonic structures - Abstract
External morphology of eggs of Tipula (Lunatipula) decolor Mannheims, Tipula (Lunatipula) dedecor Loew, and Tipula (Acutipula) latifurca Vermoolen were studied with both light and scanning electron microscopy. Mating pairs of these species were collected and maintained under laboratory conditions. Eggs were laid singly and were usually well separated from each other in cotton fiber batting. Eggs of these species are oval and black. The surface of the egg of T decolor was covered by chorionic protrusions of similar size, and there was a single micropylar opening at the anterior end of egg. The egg surface of T dedecor was covered with low protrusions with sharp tips, and there were numerous micropylar openings at the anterior end of egg. The egg surface of T latifurca was smooth and lacked chorionic protrusions, and the anterior end of egg has a disc-shaped structure formed by coiled terminal filament.
- Published
- 2005
24. Tüberkülozda Genetic Yatkınlık: IL-12 Reseptör Beta1 Eksikliği Olan 8 Vaka
- Author
-
ASLAN, AYŞE TANA, ÖZÇELİK, HAYRİYE UĞUR, YALÇIN, ELMAS EBRÜ, kuyucu, n, DOĞRU ERSÖZ, DENİZ, KİPER, EMİNE NURAL, and SANAL, ÖZDEN
- Published
- 2004
25. Brief report. Adenosine deaminase in childhood pulmonary tuberculosis: diagnostic value in serum
- Author
-
Kuyucu, N, primary
- Published
- 1999
- Full Text
- View/download PDF
26. Prevalence of respiratory syncytial virus, parainfluenza virus, influenza virus, and human metapneumovirus in children with wheezin [sic].
- Author
-
Topçuoglu S, Arslanköylü AE, Kuyucu S, and Kuyucu N
- Abstract
Copyright of Journal of Pediatric Infection / Çocuk Enfeksiyon Dergisi is the property of Journal of Pediatric Infection / Cocuk Enfeksiyon Dergisi and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2009
27. Treatment of antimicrobial-resistant gram-negative infections in children.
- Author
-
Kuyucu N
- Abstract
Copyright of Journal of Pediatric Infection / Çocuk Enfeksiyon Dergisi is the property of Journal of Pediatric Infection / Cocuk Enfeksiyon Dergisi and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2009
28. Vaccine contraindications and false contraindications.
- Author
-
Kuyucu N
- Abstract
Copyright of Journal of Pediatric Infection / Çocuk Enfeksiyon Dergisi is the property of Journal of Pediatric Infection / Cocuk Enfeksiyon Dergisi and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2008
29. BCG revaccination and tuberculin reactivity.
- Author
-
Kuyucu, Necdet, Kuyucu, Semanur, Bakirtas, Arzu, Karacan, Candemir, Kuyucu, N, Kuyucu, S, Bakirtas, A, and Karacan, C
- Subjects
TUBERCULOSIS prevention ,TUBERCULOSIS epidemiology ,BCG vaccines ,IMMUNIZATION ,REFERENCE values ,TUBERCULIN test ,DISEASE prevalence - Abstract
Interpretation of tuberculin reactions in revaccinated children is somewhat controversial among paediatricians. In this study, the effect of the number of BCG vaccines on tuberculin reactivity is evaluated. In 2810 healthy children aged 7 to 14 years with purified protein derivative (PPD) testing. Children were grouped according to the concordance of the number of the reported/documented vaccinations to the number of scars. Group 1 and 2 comprised of children 7 to 10 years of age and 11 to 14 years of age respectively, who had non-concordant scar numbers, and Group 3 and 4 included 7 to 10 and 11 to 14 years old children with concordant scar numbers. Mean tuberculin induration sizes were 8.0 +/- 5.7 mm for Group 1, 10.6 +/- 4.9 mm for Group 2, 9.8 +/- 4.9 mm for Group 3 and 10.9 +/- 4 mm for Group 4. As the time interval after the last dose of vaccination increased, mean induration sizes decreased in Group 1 and Group 3. In contrast, the mean reaction sizes of Group 2 and Group 4 showed a positive correlation with the period after the last dose of vaccine. It seems advisable that an induration size > or = 15 mm should not be attributed to BCG vaccination in countries with a high tuberculosis infection prevalence and routine BCG revaccination policies. A detailed investigation for tuberculosis infection and disease should be performed in those cases. [ABSTRACT FROM AUTHOR]
- Published
- 2001
- Full Text
- View/download PDF
30. Adenosine deaminase in childhood pulmonary tuberculosis: diagnostic value in serum.
- Author
-
Kuyucu, N, Karakurt, C, Bilaloğlu, E, Karacan, C, and Teziç, T
- Published
- 1999
- Full Text
- View/download PDF
31. Prevalence of respiratory syncytial virus, parainfluenza virus, influenza virus, and human metapneumovirus in children with wheezin,Hişiltili çocuklarda respiratuar sinsisyal virüs, parainfluenza virüs, i̇nfluenza virüs ve i̇nsan metapnömovirüs sikliǧinin araştirilmasi
- Author
-
Topçuoǧlu, S., Arslanköylü, A. E., Kuyucu, S., and Kuyucu, N.
32. Symptomatic and asymptomatic candidiasis in a pediatric intensive care unit
- Author
-
Arslankoylu Ali Ertug, Kuyucu Necdet, Yilmaz Berna, and Erdogan Semra
- Subjects
Candida ,candidiasis ,pediatric intensive care unit ,Pediatrics ,RJ1-570 - Abstract
Abstract Introduction This study aimed to examine the incidence, epidemiology, and clinical characteristics of symptomatic and asymptomatic candidiasis in a pediatric intensive care unit (PICU), and to determine the risk factors associated with symptomatic candidiasis. Methods This retrospective study included 67 patients from a 7-bed PICU in a tertiary care hospital that had Candida-positive cultures between April 2007 and July 2009. Demographic and clinical characteristics of the patients, Candida isolates, antimicrobial and antifungal treatments, and previously identified risk factors for symptomatic candidiasis were recorded, and symptomatic and asymptomatic patients were compared. Results In all, 36 (53.7%) of the patients with Candida-positive cultures had asymptomatic candidiasis and 31 (46.3%) had symptomatic candidiasis. Candida albicans was the most common Candida sp. in the asymptomatic patients (n = 20, 55.6%), versus Candida parapsilosis in the symptomatic patients (n = 15, 48.4%). The incidence of central venous catheter indwelling, blood transfusion, parenteral nutrition, and surgery was higher in the symptomatic patient group than in the asymptomatic patient group (P < 0.5). Surgery was the only independent predictor of symptomatic candidiasis according to forward stepwise multivariate logistic regression analysis (OR: 6.1; 95% CI: 1.798-20.692). Conclusion Surgery was the only risk factor significantly associated with symptomatic candidiasis and non-albicans Candida species were more common among the patients with symptomatic candidiasis. While treating symptomatic candidiasis in any PICU an increase in the incidence of non-albicans candidiasis should be considered.
- Published
- 2011
- Full Text
- View/download PDF
33. Surgical site infection rates in 16 cities in Turkey: findings of the International Nosocomial Infection Control Consortium (INICC)
- Author
-
Ahmet Şahin, Iftihar Koksal, Gaye Usluer, Hülya Sungurtekin, Tanıl Kendirli, Selçuk Kaya, Eylul Gumus, Gürdal Yýlmaz, Mehmet Faruk Geyik, Ertugrul Guclu, Nurettin Erben, Tuna Demirdal, Tuncer Haznedaroglu, Huseyin Turgut, Levent Gorenek, Erdal Ince, Melek Güneş, Hava Yilmaz, Necdet Kuyucu, Suzan Sacar, Alper Şener, Oguz Dursun, Nefise Oztoprak, Ahmet Dilek, Fatma Sirmatel, Ergin Çiftçi, Meliha Meric, Gulsume Kaya, Mustafa Sunbul, Metin Otkun, Emel Azak, Fatma Ülger, Gülden Ersöz, Yunus Gürbüz, Ayşe Willke, Sehnaz Kaya, Hakan Leblebicioglu, Oral Oncul, Davut Ozdemir, Nevin Taşyapar, Ali Acar, Ediz Tutuncu, Zeynep Kaya, Doğaç Uğurcan, Oguz Karabay, Victor D. Rosenthal, Fazilet Duygu, Saban Esen, Ali Kaya, Ata Nevzat Yalcin, Hülya Ulusoy, Gunes Senol, Adem Karbuz, Turan Aslan, Özge Turhan, Selvi Erdogan, Cengiz Uzun, Ilhan Ozgunes, Leblebicioglu, H, Erben, N, Rosenthal, VD, Sener, A, Uzun, C, Senol, G, Ersoz, G, Demirdal, T, Duygu, F, Willke, A, Sirmatel, F, Oztoprak, N, Koksal, I, Oncul, O, Gurbuz, Y, Guclu, E, Turgut, H, Yalcin, AN, Ozdemir, D, Kendirli, T, Aslan, T, Esen, S, Ulger, F, Dilek, A, Yilmaz, H, Sunbul, M, Ozgunes, I, Usluer, G, Otkun, M, Kaya, A, Kuyucu, N, Kaya, Z, Meric, M, Azak, E, Yylmaz, G, Kaya, S, Ulusoy, H, Haznedaroglu, T, Gorenek, L, Acar, A, Tutuncu, E, Karabay, O, Kaya, G, Sacar, S, Sungurtekin, H, Ugurcan, D, Turhan, O, Gumus, E, Dursun, O, Geyik, MF, Sahin, A, Erdogan, S, Ince, E, Karbuz, A, Ciftci, E, Tasyapar, N, Gunes, M, Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü, Güçlü, Ertuğrul, MERİÇ KOÇ, MELİHA, and Ondokuz Mayıs Üniversitesi
- Subjects
Turkey ,Epidemiology ,Surgical wound infection ,Health careeassociated infection ,Turkey (republic) ,Cohort Studies ,hip prosthesis ,Nosocomial infection ,Prospective Studies ,hospital ,Prospective cohort study ,Health Policy ,craniotomy ,clinical trial ,cohort analysis ,Hospitals ,hospital patient ,Infectious Diseases ,Cohort ,Surgical site infection ,Cohort study ,prospective study ,medicine.medical_specialty ,Health care-associated infection ,prevalence ,education ,infection rate ,surgical infection ,Article ,Developing countries ,coronary artery bypass graft ,Internal medicine ,medicine ,Humans ,Hospital infection ,human ,Cities ,cesarean section ,business.industry ,Public Health, Environmental and Occupational Health ,findings of the International Nosocomial Infection Control Consortium (INICC)-, AMERICAN JOURNAL OF INFECTION CONTROL, cilt.43, ss.48-52, 2015 [Leblebicioglu H., Erben N., ROSENTHAL V. D. , ŞENER A., UZUN C., SENOL G., Ersoz G., Demirdal T., DUYGU F., Willke A., et al., -Surgical site infection rates in 16 cities in Turkey] ,Nosocomial infection control ,Confidence interval ,shunting ,Surgery ,Clinical trial ,multicenter study ,city ,business - Abstract
Yalcin, Ata Nevzat/0000-0002-7243-7354; dursun, oguz/0000-0001-5482-3780; Oncul, Oral/0000-0002-1681-1866; Leblebicioglu, Hakan/0000-0002-6033-8543; demirdal, tuna/0000-0002-9046-5666; Ciftci, Ergin/0000-0002-4955-160X; Erben, Nurettin/0000-0003-0373-0132; Kendirli, Tanil/0000-0001-9458-2803; Acar, Ali/0000-0003-2008-5112; Geyik, Mehmet Faruk/0000-0002-0906-0902; Dursun, Oguz/0000-0001-5482-3780; KAYA, ZEYNEP/0000-0002-8468-2103; KARABAY, OGUZ/0000-0003-1514-1685; Karabay, Oguz/0000-0003-0502-432X; Kaya, Sehnaz/0000-0003-0002-1517 WOS: 000347654600011 PubMed: 25564124 Background: Surgical site infections (SSIs) are a threat to patient safety; however, there were no available data on SSI rates stratified by surgical procedure (SP) in Turkey. Methods: Between January 2005 and December 2011, a cohort prospective surveillance study on SSIs was conducted by the International Nosocomial Infection Control Consortium (INICC) in 20 hospitals in 16 Turkish cities. Data from hospitalized patients were registered using the Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN) methods and definitions for SSIs. Surgical procedures (SPs) were classified into 22 types according to International Classification of Diseases, Ninth Revision criteria. Results: We recorded 1879 SSIs, associated with 41,563 SPs (4.3%; 95% confidence interval, 4.3-4.7). Among the results, the SSI rate per type of SP compared with rates reported by the INICC and CDC NHSN were 11.9% for ventricular shunt (vs 12.9% vs 5.6%); 5.3% for craniotomy (vs 4.4% vs 2.6%); 4.9% for coronary bypass with chest and donor incision (vs 4.5 vs 2.9); 3.5% for hip prosthesis (vs 2.6% vs 1.3%), and 3.0% for cesarean section (vs 0.7% vs 1.8%). Conclusions: In most of the 22 types of SP analyzed, our SSI rates were higher than the CDC NHSN rates and similar to the INICC rates. This study advances the knowledge of SSI epidemiology in Turkey, allowing the implementation of targeted interventions. Copyright (C) 2015 by the Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
- Published
- 2015
34. Analysis of wound infections among pediatric patients following the 2023 Türkiye-Syria earthquakes.
- Author
-
Yeşil E, Tezol Ö, Gokay N, Sürmeli Döven S, Mısırlıoğlu M, Akça M, Özgökçe Özmen B, Dikme G, Durak F, Alakaya M, Karahan F, Kıllı İ, and Kuyucu N
- Subjects
- Humans, Female, Male, Child, Turkey epidemiology, Child, Preschool, Adolescent, Syria epidemiology, Risk Factors, Anti-Bacterial Agents therapeutic use, Incidence, Infant, Earthquakes, Wound Infection epidemiology, Wound Infection microbiology
- Abstract
Purpose: On February 6, 2023, two earthquakes of magnitude 7.7 and 7.6 occurred consecutively in Turkey and Syria. This study aimed to investigate the predisposing factors for wound infection (WI) and the microbiological characteristics of wounds after earthquake-related injuries., Methods: This descriptive study evaluated pediatric patients' frequency of WI, and the clinical and laboratory parameters associated with the development of WI were investigated., Results: The study included 180 patients (91 female). The mean age of the patients was 123.9 ± 64.9 months and 81.7% (n = 147) of them had been trapped under rubble. Antibiotic treatment to prevent WI had been administered to 58.8% (n = 106) of all patients. WI was observed in 12.2% (n = 22) of the cases. In patients who developed WI, the incidence of exposure to a collapse, crush syndrome, compartment syndrome, multiple extremity injury, fasciotomy, amputation, peripheral nerve injury, thoracic compression, blood product use, intubation, and the use of central venous catheters, urinary catheters, and thoracic tubes were more frequent (p < 0.05). The need for blood product transfusion was associated with the development of WI (OR = 9.878 [95% CI: 2.504-38.960], p = 0.001). The negative predictive values of not developing WI at values of white blood cell count of < 11,630/mm
3 , creatine kinase < 810 U/L, potassium < 4.1 mEq/L, ALT < 29 U/L, AST < 32 U/L, and CRP < 45.8 mg/L were 93.7%, 96.8%, 90.8%, 93.3%, 100%, and 93.5%, respectively. Gram-negative pathogens (81%) were detected most frequently in cases of WI. Seventy-five percent of patients were multidrug- and extensively drug-resistant., Conclusion: This study leans empirical approach of our disaster circumstances. In cases with risk factors predisposing to the development of WI, it may be rational to start broad-spectrum antibiotics while considering the causative microorganisms and resistance profile to prevent morbidity., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
35. COVID-19 in hospitalized infants aged under 3 months: multi-center experiences across Turkey.
- Author
-
Üstündağ G, Karadag-Oncel E, Kara-Ulu N, Polat M, Salı E, Çakır D, Şahin A, Akaslan-Kara A, Kaçar P, Işık AD, Erdemli PC, Durmuş SY, Özdemir A, Çelik B, Sütçü M, Kara M, Kandemir-Gülmez T, Çelikyurt A, Ümit Z, Aktürk H, Arıkan K, Kaba Ö, Caymaz C, Bayhan C, Aygün D, Penezoğlu DN, Alataş ŞÖ, Özdemir H, Türel Ö, Akça M, Çelebi-Çongur E, Kepenekli E, Çelik Ü, Ecevit İZ, Belet N, Dalgıç N, Yılmaz N, Yılmaz D, Kuyucu N, and Çiftçi E
- Subjects
- Female, Humans, Infant, Infant, Newborn, Male, Chronic Disease, Cough etiology, Cross-Sectional Studies, Turkey epidemiology, COVID-19 epidemiology, COVID-19 complications
- Abstract
To investigate coronavirus disease 2019 (COVID-19) in infants aged 0 to 3 months because there is currently a significant gap in the literature on the subject. A cross-sectional study was conducted with the involvement of 19 medical centers across Turkey and 570 infants. The majority of the patients were male (58.2%), and the three most common symptoms were fever (78.2%), cough (44.6%), and feeding intolerance (39.9%). The results showed that a small percentage of infants had positive blood (0.9%) or urine cultures (10.2%). Most infants presented with fever (78.2%). Children without underlying conditions (UCs) had mostly a complicated respiratory course and a normal chest radiography. Significant more positive urine culture rates were observed in infants with fever. A higher incidence of respiratory support requirements and abnormal chest findings were seen in infants with chronic conditions. These infants also had a longer hospital stay than those without chronic conditions. Conclusions: Our study discloses the clinical observations and accompanying bacterial infections found in infants aged under 3 months with COVID-19. These findings can shed light on COVID-19 in infancy for physicians because there is limited clinical evidence available. What is Known: • COVID-19 in infants and older children has been seen more mildly than in adults. • The most common symptoms of COVID-19 in infants are fever and cough, as in older children and adults. COVID-19 should be one of the differential diagnoses in infants with fever. What is New: • Although most infants under three months had fever, the clinical course was uneventful and respiratory complications were rarely observed in healthy children. • Infants with underlying conditions had more frequent respiratory support and abnormal chest radiography and stayed longer in the hospital., (© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
36. Assessing autonomic activity and prognostic risk factors comparing multisystem inflammatory syndrome and isolated viral myocarditis/myopericarditis.
- Author
-
Duman D, Karpuz D, Taşdelen B, and Kuyucu N
- Subjects
- Child, Humans, Prognosis, Heart Rate physiology, Autonomic Nervous System, Risk Factors, Myocarditis diagnosis, COVID-19 complications, Systemic Inflammatory Response Syndrome
- Abstract
Introduction and Aim: In pediatric multisystem inflammatory syndrome and isolated viral myocarditis/myopericarditis, autonomic nervous system function can be evaluated by a non-invasive method called heart rate variability. This study aims to evaluate heart rate variability in these two groups by comparing them with each other. This is the first study assessing these values in these two groups of patients., Method: Patients who are diagnosed with multisystem inflammatory syndrome in children and isolated viral myocarditis/myopericarditis at a university hospital from September 2021 to February 2023 are screened by electrocardiography, echocardiography, and 24-hour Holter monitoring. A healthy control group, compatible in age and gender with the patient groups, was selected from healthy subjects that applied to the hospital for palpitation, murmur, and/or chest pain. Heart rate variability parameters and related laboratory markers were analyzed and compared among the three groups., Results: There were 30 patients with multisystem inflammatory syndrome in children, 43 patients with isolated viral myocarditis/myopericarditis, and 109 participants in the healthy control group. Statistically significant differences were found in most of the heart rate variability parameters: standard deviation of normal to normal intervals (SDNN), the mean of the 5- minute RR interval standard deviations (SDNNİ), the standard deviation of 5-minute R wave to R wave(RR) interval means (SDANN), the root mean square of successive RR interval differences (RMSSD), and the percentage of the beats with a consecutive RR interval difference of more than 50 ms (pNN50%), very low frequency, high frequency, low frequency, triangular index, and low frequency/high-frequency ratio. Multisystem inflammatory syndrome in children patients had impaired and declined heart rate variability values compared to the other two groups. In patients with myocarditis/myopericarditis, we couldn't find a significant difference in these parameters with the control group., Conclusion: Heart rate variability can be used as an important non-invasive autonomic function parameter in determining prognosis and treatment plans, especially in patients diagnosed with multisystem inflammatory syndrome in children. This impairment of autonomic activity could be more prominent in patients with decreased left ventricular systolic functions.
- Published
- 2024
- Full Text
- View/download PDF
37. Pathogens in Pediatric Septic Arthritis: A Multi-Center Study in Turkiye (PEDSART Study).
- Author
-
Iseri Nepesov M, Kilic O, Sali E, Yesil E, Akar A, Kaman A, Metin Akcan O, Kilic Cil M, Ozlu C, Lacinel Gurlevik S, Ulusoy E, Cetin BS, Akici N, Cakir D, Uslu Aygun FD, Hancerli CO, Tekin Yilmaz A, Alkan G, Uygun H, Bucak IH, Bursal B, Celik T, Sutcu M, Oz FN, Gayretli Aydin ZG, Karbuz A, Akturk H, Kepenekli E, Emiroglu M, Oncel S, Nuhoglu C, Korucu IH, Incesu M, Kaya A, Bombaci H, Dinleyici M, Carman KB, Duman M, Turel O, Yilmaz D, Alabaz D, Belet N, Tanir G, Turgut M, Celebi S, Kuyucu N, Arisoy ES, Durmaz G, Kaya M, Kara A, and Dinleyici EC
- Abstract
Objectives: Septic arthritis (SA) is a serious bacterial infection that must be treated efficiently and timely. The large number of culture-negative cases makes local epidemiological data important. Accordingly, this study aimed to evaluate the etiology, clinical characteristics, and therapeutic approach of SA in children in Turkiye, emphasizing the role of real-time polymerase chain reaction (PCR) techniques in the diagnosis., Methods: In this multi-center, prospective study, children hospitalized due to SA between February 2018 and July 2020 in 23 hospitals in 14 cities in Turkiye were included. Clinical, demographic, laboratory, and radiological findings were assessed, and real-time PCR was performed using synovial fluid samples., Results: Seventy-five children aged between 3 and 204 months diagnosed with acute SA were enrolled. Joint pain was the main complaint at admission, and the most commonly involved joints were the knees in 58 patients (77.4%). The combination of synovial fluid culture and real-time PCR detected causative bacteria in 33 patients (44%). In 14 (18.7%) patients, the etiological agent was demonstrated using only PCR. The most commonly isolated etiologic agent was Staphylococcus aureus , which was detected in 22 (29.3%) patients, while Streptococcus pyogenes was found in 4 (5.3%) patients and Kingella kingae in 3 (4%) patients. Streptococcus pyogenes and Kingella kingae were detected using only PCR. Most patients (81.3%) received combination therapy with multiple agents, and the most commonly used combination was glycopeptides plus third-generation cephalosporin., Conclusions: Staphylococcus aureus is the main pathogen in pediatric SA, and with the use of advanced diagnostic approaches, such as real-time PCR, the chance of diagnosis increases, especially in cases due to Kingella kingae and Streptococcus pyogenes.
- Published
- 2024
- Full Text
- View/download PDF
38. Evaluation of 601 children with multisystem inflammatory syndrome (Turk MISC study).
- Author
-
Yilmaz D, Ekemen Keles Y, Emiroglu M, Duramaz BB, Ugur C, Aldemir Kocabas B, Celik T, Ozdemir H, Bayturan S, Turel O, Erdeniz EH, Cakici O, Cakmak Taskin E, Erbas İC, Genceli M, Sari EE, Caymaz C, Kizil MC, Sutcu M, Demirbuga A, Alkan G, Bagcı Z, Timurtas Dayar G, Ozkan EA, Tekin Yilmaz A, Akca M, Yesil E, Kara SS, Akturk H, Yasar B, Umit Z, Uygun H, Erdem N, Buyukcam A, Karadag Oncel E, Tuter Oz SK, Cetin HS, Anil AB, Yilmaz R, Zengin N, Uzuner S, Albayrak H, Borakay O, Topal S, Arslan G, Yazar A, Ozer A, Kendirli T, Kara EM, Demirkol D, Battal F, Kosker M, Metin Akcan O, Kihtir HS, Gul D, Zararci K, Alakaya M, Kula N, Celik E, Petmezci E, Evren G, Kara Aksay A, Konca C, Sert A, Arslan D, Bornaun H, Tekeli O, Bal A, Sahin IO, Demir S, Sap F, Akyol MB, Tanidir IC, Donmez YN, Ucar T, Coban S, Arga G, Hancerli Torun S, Karpuz D, Celik SF, Varan C, Elmali F, Oncel S, Belet N, Hatipoglu N, Dalgic Karabulut N, Turgut M, Somer A, Kuyucu N, Dinleyici EC, Ciftci E, and Kara A
- Subjects
- Child, Humans, Infant, Newborn, Infant, Child, Preschool, Procalcitonin, Intensive Care Units, Ferritins, Troponin, Retrospective Studies, Mucocutaneous Lymph Node Syndrome
- Abstract
Purpose: Due to its link with the 2019 coronavirus, the multisystem inflammatory syndrome in children (MISC) has garnered considerable international interest. The aim of this study, in which MISC patients were evaluated multicenter, and the data of the third period of the Turk-MISC study group, to compare the clinical and laboratory characteristics and outcomes of MISC patients who did and did not require admission to an intensive care unit (ICU)., Methods: This retrospective multicenter observational study was carried out between June 11, 2021, and January 01, 2022. The demographics, complaints, laboratory results, system involvements, and outcomes of the patients were documented., Results: A total of 601 patients were enrolled; 157 patients (26.1%) required hospitalization in the intensive care unit (ICU). Median age was 8 years (interquartile range (IQR) 4.5-11.3 years. The proportion of Kawasaki disease-like features in the ICU group was significantly higher than in the non-ICU group (56.1% vs. 43.2% p = 0.006). The ICU group had considerably lower counts of both lymphocytes and platelets (lymphocyte count 900 vs. 1280 cells × μL, platelet count 153 vs. 212 cells × 10
3 / μL, all for p< 0.001). C-reactive protein, procalcitonin, and ferritin levels were significantly higher in the ICU group (CRP 164 vs. 129 mg/L, procalcitonin 9.2 vs. 2.2 μg/L, ferritin 644 vs. 334 μg/L, all for p< 0.001). Being between ages 5-12 and older than 12 increased the likelihood of hospitalization in the ICU by four [95% confidence intervals (CI)1.971-8.627] and six times (95% CI 2.575-14.654), respectively, compared to being between the ages 0-5. A one-unit increase in log D-dimer (µg/L) and log troponin (ng/L) was also demonstrated to increase the need for intensive care by 1.8 (95% CI 1.079-3.233) and 1.4 times (95% CI 1.133-1.789), respectively. Conclusion: By comparing this study to our other studies, we found that the median age of MISC patients has been rising. Patients requiring an ICU stay had considerably higher levels of procalcitonin, CRP, and ferritin but significantly lower levels of lymphocyte and thrombocyte. In particular, high levels of procalcitonin in the serum might serve as a valuable laboratory marker for anticipating the need for intensive care., What Is Known: • Lymphopenia and thrombocytopenia were an independent predictor factors in patients with MISC who needed to stay in intensive care unit. • The possibility of the need to stay in the intensive care unit in patients with MISC who had Kawasaki disease-like findings was controversial compared with those who did not., What Is New: • A one-unit increase log D dimer and log troponin was demonstrated to require for intensive care unit by 1.8 and 1.4 times, respectively. • Serum procalcitonin levels had the best performance to predict stay in the intensive care unit stay., (© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)- Published
- 2023
- Full Text
- View/download PDF
39. Evaluation of Intestinal Microbiota in Children With Sickle Cell Disease.
- Author
-
Karahan F, Yilmaz SS, Bayrakdar F, Tezol Ö, Kuyucu N, Kiliç S, Türkegün M, and Ünal S
- Subjects
- Adolescent, Humans, Child, C-Reactive Protein, RNA, Ribosomal, 16S, Acute Chest Syndrome, Gastrointestinal Microbiome, Anemia, Sickle Cell therapy, Vascular Diseases
- Abstract
Background and Aims: Sickle cell disease (SCD) is a chronic hemolytic anemia that may be life-threatening due to multisystemic effects. Identification of the factors which affect the pathophysiology of the disease is important in reducing mortality and morbidity. This study aimed to determine gut microbial diversity in children and adolescents with SCA compared with healthy volunteers and to evaluate the clinical impact of microbiota., Materials and Methods: The study included 34 children and young adolescents with SCD and 41 healthy volunteer participants. The microbiome was assessed by 16S rRNA sequencing in stool samples. Laboratory parameters of all participants, such as complete blood count and C-reactive protein values and clinical characteristics of SCD patients, were determined and compared, as well as clinical conditions of the patients, such as vascular occlusive crisis and/or acute chest syndrome, frequency of transfusions, intake of penicillin, hydroxyurea, and chelation therapy were recorded., Results: White blood cell count, hemoglobin, immature granulocyte and C-reactive protein levels were significantly higher in the patient group ( P <0.05). Microbiota analysis revealed 3 different clusters among subjects; controls and 2 clusters in the SCD patients (patient G1 and G2 groups). Bacteroides spp. were more prevalent, while Dialester spp. and Prevotella spp. were less prevalent in SCD compared with controls ( t =2.142, P <0.05). Patient G2 (n=9) had a higher prevalence of Bacteroides and a lower prevalence of Prevotella than patient G1 (n=25)., Conclusion: In our study, there was a difference between SCD patients and the control group, while 2 different microbiota profiles were encountered in SCD patients. This difference between the microbiota of the patients was not found to affect the clinical picture (such as vascular occlusive crisis, acute chest syndrome)., Competing Interests: The authors declare no conflict of interest., (Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
40. A snapshot of pediatric inpatients and outpatients with COVID-19: a point prevalence study from Turkey.
- Author
-
Yılmaz D, Üstündağ G, Büyükçam A, Salı E, Çelik Ü, Avcu G, Belet N, Çakmak Taşkın E, Öcal Demir S, Birbilen AZ, Kılıç Ö, Metin Akcan Ö, Tekin Yılmaz A, Aldemir Kocabaş B, Hatipoğlu N, Karbuz A, Çakır D, Sütçü M, Aygün FD, Çelik T, Bayturan Şen S, Dalgıç N, Ümit Z, Kara SS, Karadağ Öncel E, Bolat A, Kılıç Çil M, Turan C, Çakıl Güzin A, Topal S, Esen Besli G, Doğan G, Şahin S, Akın F, Bildirici Y, Timurtaş Dayar G, Ergül Sarı E, Kızmaz İşançlı D, Kara M, Önal P, Aylaç H, Lüleci D, Yaşar B, Dede E, Çağlar A, Akova S, Afat Turgut E, Yazıcı Özkaya P, Kandemir Gülmez T, Ulusoy E, Duyu M, Kara Y, Çeliktaş H, Tekeli O, Çağlar F, Gül D, Oral Cebeci S, Battal F, Bal A, Aygün E, Uysalol M, Arslan G, Özkavaklı A, Kızıl MC, Yazar A, Aygün F, Somer A, Kuyucu N, Dinleyici EÇ, and Kara A
- Subjects
- Adult, Humans, Child, Female, Aged, Male, SARS-CoV-2, COVID-19 Vaccines, Outpatients, Cough, Inpatients, Turkey epidemiology, Prevalence, Obesity, Chronic Disease, COVID-19 epidemiology
- Abstract
This multi-center point prevalence study evaluated children who were diagnosed as having coronavirus disease 2019 (COVID-19). On February 2nd, 2022, inpatients and outpatients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were included in the study from 12 cities and 24 centers in Turkey. Of 8605 patients on February 2nd, 2022, in participating centers, 706 (8.2%) had COVID-19. The median age of the 706 patients was 92.50 months, 53.4% were female, and 76.7% were inpatients. The three most common symptoms of the patients with COVID-19 were fever (56.6%), cough (41.3%), and fatigue (27.5%). The three most common underlying chronic diseases (UCDs) were asthma (3.4%), neurologic disorders (3.3%), and obesity (2.6%). The SARS-CoV-2-related pneumoniae rate was 10.7%. The COVID-19 vaccination rate was 12.5% in all patients. Among patients aged over 12 years with access to the vaccine given by the Republic of Turkey Ministry of Health, the vaccination rate was 38.7%. Patients with UCDs presented with dyspnea and pneumoniae more frequently than those without UCDs (p < 0.001 for both). The rates of fever, diarrhea, and pneumoniae were higher in patients without COVID-19 vaccinations (p = 0.001, p = 0.012, and p = 0.027). Conclusion: To lessen the effects of the disease, all eligible children should receive the COVID-19 vaccine. The illness may specifically endanger children with UCDs. What is Known: • Children with COVID-19 mainly present with fever and cough, as in adults. • COVID-19 may specifically threaten children with underlying chronic diseases. What is New: • Children with obesity have a higher vaccination rate against COVID-19 than children without obesity. • Among unvaccinated children, fever and pneumoniae might be seen at a higher ratio than among vaccinated children., (© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
41. [Severe Encephalitis with Human Herpes Virus-7 (HHV-7) Associated Transient Splenial Lesion in an Immunocompetent Child: A Case Report].
- Author
-
Akça M, Özgökçe Özmen B, Ersoy Ö, Çobanoğulları Direk M, and Kuyucu N
- Subjects
- Humans, Child, Female, Infant, Antiviral Agents therapeutic use, Foscarnet therapeutic use, Acyclovir therapeutic use, Herpesvirus 7, Human, Encephalitis
- Abstract
Encephalitis is the inflammation of the brain parenchyma accompanied by mental or behavioral neurological dysfunction, sensory or motor deficits, speech or movement disorders, and seizure. Encephalitis is an acute, life-threatening emergency that requires prompt recognition and a systematic approach for appropriate management. Human herpes virus (HHV-7) is one of the causative agents of encephalitis. In this report, a three years and six months old girl admitted to the hospital with the complaints of fever, cough, gushing vomiting, and altered consciousness, with fever, neck stiffness and blurred consciousness in her physical examination, and positive HHV-7 DNA polymerase chain reaction (PCR) in the cerebrospinal fluid (CSF) was presented. The CSF biochemistry of the patient was normal, and lymphocytic pleocytosis was detected in the CSF. Electroencephalography of the case revealed a cerebral dysfunction and hyperexcitability due to background activity abnormalities, and a cytotoxic transient lesion of the splenium in cranial magnetic resonance imaging. A 14-day foscarnet treatment was given to the patient after she progressed under empirical acyclovir treatment and HHV-7 was found to be the causative agent in the CSF. The patient was cured with the treatment and was followed up on an outpatient basis without any sequelae. In general, HHV-7 is estimated to be a common cause of pediatric acute encephalitis cases. It has been observed in the literature that almost all of the HHV-7-associated encephalitis cases occur after the age of six years, suggesting that HHV-7 causes neurological disease in children as a late infection. This case was three years and six months old and it was thought that she had encephalitis during primary infection. With this case report, we contributed to the literature by presenting a case of encephalitis in an immunocompetent pediatric patient with a transient splenial lesion associated with HHV-7, which progressed with empirical acyclovir treatment and responded to foscarnet treatment.
- Published
- 2023
- Full Text
- View/download PDF
42. Evaluation of possible COVID-19 reinfection in children: A multicenter clinical study.
- Author
-
Erbaş İC, Keleş YE, Erdeniz EH, Yılmaz AT, Yeşil E, Çakıcı Ö, Akça M, Ulu NK, Dinç F, Çiftdoğan DY, Öncel S, Kuyucu N, Tapısız A, and Belet N
- Subjects
- Adult, Humans, Child, Adolescent, Reinfection epidemiology, Retrospective Studies, COVID-19 diagnosis, COVID-19 epidemiology
- Abstract
Background: Although it was originally unknown whether there would be cases of reinfection of coronavirus disease 2019 (COVID-19) as seen with other coronaviruses, cases of reinfection were reported from various regions recently. However, there is little information about reinfection in children., Methods: In this study, we aimed to investigate the incidence and clinical findings of reinfection in pediatric patients who had recovered from COVID-19. We retrospectively evaluated all patients under 18 years of age with COVID-19 infection from a total of eight healthcare facilities in Turkey, between March 2020 and July 2021. Possible reinfection was defined as a record of confirmed COVID-19 infection based on positive reverse transcription-polymerase chain reaction (RT-PCR) test results at least 3 months apart., Results: A possible reinfection was detected in 11 out of 8840 children, which yielded an incidence of 0.12%. The median duration between two episodes of COVID-19 was 196 (92-483) days. When initial and second episodes were compared, the rates of symptomatic and asymptomatic disease were similar for both, as was the severity of the disease (p = 1.000). Also, there was no significant difference in duration of symptoms (p = 0.498) or in hospitalization rates (p = 1.000). Only one patient died 15 days after PCR positivity, which resulted in a 9.1% mortality rate for cases of reinfection in pediatric patients., Conclusion: We observed that children with COVID-19 were less likely to be exposed to reinfection when compared with adults. Although the clinical spectrum of reinfection was mostly similar to the first episode, we reported death of a healthy child during the reinfection., Competing Interests: Declaration of Competing Interest None., (Copyright © 2023 French Society of Pediatrics. Published by Elsevier Masson SAS. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
43. Should Perirectal Swab Culture Be Performed in Cases Admitted to the Neonatal Intensive Care Unit? Lessons Learned from the Neonatal Intensive Care Unit.
- Author
-
Orman A, Celik Y, Evik G, Ersöz G, Kuyucu N, and Ozmen BO
- Abstract
Serial perirectal swabs are used to identify colonization of multidrug-resistant bacteria and prevent spread. The purpose of this study was to determine colonization with carbapenem-resistant Enterobacterales (CRE) and vancomycin-resistant Enterococci (VRE). An additional purpose was to establish whether sepsis and epidemic associated with these factors were present in the neonatal intensive care unit (NICU), to which infants with hospital stays exceeding 48 h in an external healthcare center NICU were admitted. Perirectal swab samples were collected in the first 24 h by a trained infection nurse using sterile cotton swabs moistened with 0.9% NaCl from patients admitted to our unit after hospitalization exceeding 48 h in an external center. The primary outcome was positivity in perirectal swab cultures, and the secondary outcomes were whether this caused invasive infection and significant NICU outbreaks. A total of 125 newborns meeting the study criteria referred from external healthcare centers between January 2018 and January 2022 were enrolled. Analysis revealed that CRE constituted 27.2% of perirectal swab positivity and VRE 4.8%, and that one in every 4.4 infants included in the study exhibited perirectal swab positivity. The detection of colonization by these microorganisms, and including them within the scope of surveillance, is an important factor in the prevention of NICU epidemics.
- Published
- 2023
- Full Text
- View/download PDF
44. Prevalence of Anosmia in 10.157 Pediatric COVID-19 Cases: Multicenter Study from Turkey.
- Author
-
Elvan-Tuz A, Karadag-Oncel E, Kiran S, Kanik-Yuksek S, Gulhan B, Hacimustafaoglu M, Ozdem-Alatas S, Kuyucu N, Ozdemir H, Egil O, Elmas-Bozdemir S, Polat M, Bursal-Duramaz B, Cem E, Apaydin G, and Teksam O
- Subjects
- Adolescent, Adult, Anosmia epidemiology, Child, Cohort Studies, Humans, Prevalence, Prospective Studies, SARS-CoV-2, Turkey epidemiology, Ageusia diagnosis, COVID-19 complications, COVID-19 epidemiology
- Abstract
Introduction: COVID-19-related anosmia is a remarkable and disease-specific finding. With this multicenter cohort study, we aimed to determine the prevalence of anosmia in pediatric cases with COVID-19 from Turkey and make an objective assessment with a smell awareness questionnaire., Material and Methods: This multicenter prospective cohort study was conducted with pediatric infection clinics in 37 centers in 19 different cities of Turkey between October 2020 and March 2021. The symptoms of 10.157 COVID-19 cases 10-18 years old were examined. Age, gender, other accompanying symptoms, and clinical severity of the disease of cases with anosmia and ageusia included in the study were recorded. The cases were interviewed for the smell awareness questionnaire at admission and one month after the illness., Results: Anosmia was present in 12.5% (1.266/10.157) of COVID-19 cases 10-18 years of age. The complete records of 1053 patients followed during the study period were analyzed. The most common symptoms accompanying symptoms with anosmia were ageusia in 885 (84%) cases, fatigue in 534 cases (50.7%), and cough in 466 cases (44.3%). Anosmia was recorded as the only symptom in 84 (8%) of the cases. One month later, it was determined that anosmia persisted in 88 (8.4%) cases. In the smell awareness questionnaire, the score at admission was higher than the score one month later (P < 0.001)., Discussion: With this study, we have provided the examination of a large case series across Turkey. Anosmia and ageusia are specific symptoms seen in cases of COVID-19. With the detection of these symptoms, it should be aimed to isolate COVID-19 cases in the early period and reduce the spread of the infection. Such studies are important because the course of COVID-19 in children differs from adults and there is limited data on the prevalence of anosmia., Competing Interests: The authors have no conflicts of interest to disclose., (Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
45. COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group.
- Author
-
Yilmaz Ciftdogan D, Ekemen Keles Y, Cetin BS, Dalgic Karabulut N, Emiroglu M, Bagci Z, Buyukcam A, Erdeniz EH, Arga G, Yesil E, Cakici O, Karbuz A, Sahbudak Bal Z, Kara SS, Ozer A, Metin Akcan O, Elmas Bozdemir S, Anil AB, Uygun H, Kilic O, Hancerli Torun S, Umit Z, Sutcu M, Ozgokce Ozmen B, Karaoglu Asrak H, Alkan G, Kara Aksay A, Ugur C, Birbilen AZ, Bursal Duramaz B, Akyuz Ozkan E, Burakay O, Yildirim Arslan S, Karadag Oncel E, Celik SF, Kilic AO, Ozen S, Sarikaya R, Demirkol D, Arslan G, Turel O, Sert A, Sari E, Orbak Z, Sahin IO, Varan C, Akturk H, Tuter Oz SK, Durak F, Oflaz MB, Kara M, Karpuz D, Talip Petmezci M, Hatipoglu N, Oncel S, Turgut M, Elmali F, Somer A, Kuyucu N, Dinleyici EC, Kurugöl Z, Ciftci E, and Kara A
- Subjects
- Child, Child, Preschool, Humans, Lethargy, Procalcitonin, Retrospective Studies, SARS-CoV-2, Systemic Inflammatory Response Syndrome, COVID-19 complications, COVID-19 diagnosis, Mucocutaneous Lymph Node Syndrome complications, Mucocutaneous Lymph Node Syndrome diagnosis, Mucocutaneous Lymph Node Syndrome drug therapy
- Abstract
Multisystemic inflammatory syndrome (MIS-C) diagnosis remains difficult because the clinical features overlap with Kawasaki disease (KD). The study aims to highlight the clinical and laboratory features and outcomes of patients with MISC whose clinical manifestations overlap with or without KD. This study is a retrospective analysis of a case series designed for patients aged 1 month to 18 years in 28 hospitals between November 1, 2020, and June 9, 2021. Patient demographics, complaints, laboratory results, echocardiographic results, system involvement, and outcomes were recorded. A total of 614 patients were enrolled; the median age was 7.4 years (interquartile range (IQR) 3.9-12 years). A total of 277 (45.1%) patients with MIS-C had manifestations that overlapped with KD, including 92 (33.3%) patients with complete KD and 185 (66.7%) with incomplete KD. Lymphocyte and platelet counts were significantly lower in patients with MISC, overlapped with KD (lymphocyte count 1080 vs. 1280 cells × μL, p = 0.028; platelet count 166 vs. 216 cells × 10
3 /μL, p < 0.001). The median serum procalcitonin levels were statistically higher in patients overlapped with KD (3.18 vs. 1.68 µg/L, p = 0.001). Coronary artery dilatation was statistically significant in patients with overlap with KD (13.4% vs. 6.8%, p = 0.007), while myocarditis was significantly more common in patients without overlap with KD features (2.6% vs 7.4%, p = 0.009). The association between clinical and laboratory findings and overlap with KD was investigated. Age > 12 years reduced the risk of overlap with KD by 66% (p < 0.001, 95% CI 0.217-0.550), lethargy increased the risk of overlap with KD by 2.6-fold (p = 0.011, 95% CI 1.244-5.439), and each unit more albumin (g/dl) reduced the risk of overlap with KD by 60% (p < 0.001, 95% CI 0.298-0.559)., Conclusion: Almost half of the patients with MISC had clinical features that overlapped with KD; in particular, incomplete KD was present. The median age was lower in patients with KD-like features. Lymphocyte and platelet counts were lower, and ferritin and procalcitonin levels were significantly higher in patients with overlap with KD., What Is Known: • In some cases of MIS-C, the clinical symptoms overlap with Kawasaki disease. • Compared to Kawasaki disease, lymphopenia was an independent predictor of MIS-C., What Is New: • Half of the patients had clinical features that overlapped with Kawasaki disease. • In patients whose clinical features overlapped with KD, procalcitonin levels were almost 15 times higher than normal. • Lethargy increased the risk of overlap with KD by 2.6-fold in MIS-C patients. • Transient bradycardia was noted in approximately 10% of our patients after initiation of treatment., (© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)- Published
- 2022
- Full Text
- View/download PDF
46. Nasopharyngeal Meningococcal Carriage among Children and Adolescents in Turkey in 2018: An Unexpected High Serogroup X Carriage.
- Author
-
Kizil MC, Kilic O, Ceyhan M, Iseri Nepesov M, Karbuz A, Kurugol Z, Hacimustafaoglu M, Celebi S, Dinleyici M, Carman KB, Bayhan C, Balliel Y, Sutcu M, Kuyucu N, Kondolot M, Kara SS, Ocal Demir S, Cay U, Gayretli Aydin ZG, Kaya M, and Dinleyici EC
- Abstract
Meningococcal carriage studies and transmission modeling can predict IMD epidemiology and used to define invasive meningococcal disease (IMD) control strategies. In this multicenter study, we aimed to evaluate the prevalence of nasopharyngeal Neisseria meningitidis ( Nm) carriage, serogroup distribution, and related risk factors in Turkey. Nasopharyngeal samples were collected from a total of 1267 children and adolescents and were tested with rt-PCR. Nm carriage was detected in 96 participants (7.5%, 95% CI 6.1-9.0), with the peak age at 13 years (12.5%). Regarding age groups, Nm carriage rate was 7% in the 0-5 age group, was 6.9%in the 6-10 age group, was 7.9% in the 11-14 age group, and was 9.3% in the 15-18 age group. There was no statistically significant difference between the groups ( p > 0.05). The serogroup distribution was as follows: 25% MenX, 9.4% MenA, 9.4% MenB, 2.1% MenC, 3.1% MenW, 2.1% for MenY, and 48.9% for non-groupable. The Nm carriage rate was higher in children with previous upper respiratory tract infections and with a high number of household members, whereas it was lower in children with antibiotic use in the last month ( p < 0.05 for all). In this study, MenX is the predominant carriage strain. The geographical distribution of Nm strains varies, but serogroup distribution in the same country might change in a matter of years. Adequate surveillance and/or a proper carriage study is paramount for accurate/dynamic serogroup distribution and the impact of the proposed vaccination.
- Published
- 2021
- Full Text
- View/download PDF
47. Multicenter Hospital-Based Prospective Surveillance Study of Bacterial Agents Causing Meningitis and Seroprevalence of Different Serogroups of Neisseria meningitidis, Haemophilus influenzae Type b, and Streptococcus pneumoniae during 2015 to 2018 in Turkey.
- Author
-
Ceyhan M, Ozsurekci Y, Tanır Basaranoglu S, Gurler N, Sali E, Keser Emiroglu M, Oz FN, Belet N, Duman M, Ulusoy E, Kurugol Z, Tezer H, Ozkaya Parlakay A, Dinleyici EC, Celik U, Celebi S, Oner AF, Solmaz MA, Karbuz A, Hatipoglu N, Devrim I, Caglar I, Bozdemir SE, Kocabas E, Gundeslioglu OO, Sutcu M, Metin Akcan O, Kuyucu N, Aktar F, Kara SS, Altay Akisoglu HO, Tuygun N, Tamburaci Uslu ZD, Karadag Oncel E, Bayhan C, and Cengiz AB
- Subjects
- Adolescent, Child, Child, Preschool, Hospitals, Humans, Infant, Meningitis, Bacterial cerebrospinal fluid, Meningitis, Bacterial microbiology, Prospective Studies, Seroepidemiologic Studies, Serogroup, Turkey epidemiology, Haemophilus influenzae type b classification, Meningitis, Bacterial epidemiology, Neisseria meningitidis classification, Streptococcus pneumoniae classification
- Abstract
The etiology of bacterial meningitis in Turkey changed after the implementation of conjugated vaccines against Streptococcus pneumoniae and Haemophilus influenzae type b (Hib) in the Turkish National Immunization Program (NIP). Administration of Hib vaccine and PCV-7 (7-valent pneumococcal conjugate vaccine) was implemented in NIP in 2006 and 2009, respectively. In 2011, PCV-7 was replaced with PCV-13. Meningococcal vaccines have not yet been included in Turkish NIP. This prospective study comprised 27 hospitals located in seven regions of Turkey and represented 45% of the population. Children aged between 1 month and 18 years who were hospitalized with suspected meningitis were included. Cerebrospinal fluid (CSF) samples were collected, and bacterial identification was made according to the multiplex PCR assay results. During the study period, 994 children were hospitalized for suspected meningitis, and Hib ( n = 3, 2.4%), S. pneumoniae ( n = 33, 26.4%), and Neisseria meningitidis ( n = 89, 71%) were detected in 125 samples. The most common meningococcal serogroup was MenB. Serogroup W comprised 13.9% ( n = 5) and 7.5% ( n = 4) of the meningococci in 2015 to 2016 and 2017 to 2018, respectively. Serogroup C was not detected. There were four deaths in the study; one was a pneumococcus case, and the others were serogroup B meningococcus cases. The epidemiology of meningococcal diseases has varied over time in Turkey. Differing from the previous surveillance periods, MenB was the most common serogroup in the 2015-to-2018 period. Meningococcal epidemiology is so dynamic that, for vaccination policies, close monitoring is crucial. IMPORTANCE Acute bacterial meningitis (ABM) is one of the most common life-threatening infections in children. The incidence and prevalence of ABM vary both geographically and temporally; therefore, surveillance systems are necessary to determine the accurate burden of ABM. The Turkish Meningitis Surveillance Group has been performing a hospital-based meningitis surveillance study since 2005 across several regions in Turkey. Meningococcus was the major ABM-causing agent during the 2015-to-2018 period, during which MenB was the dominant serogroup., (Copyright © 2020 Ceyhan et al.)
- Published
- 2020
- Full Text
- View/download PDF
48. Role of mean platelet volume-to-lymphocyte ratio in the diagnosis of childhood appendicitis.
- Author
-
Bozlu G, Akar A, Durak F, and Kuyucu N
- Subjects
- Adolescent, Appendectomy, Appendicitis blood, Appendicitis surgery, C-Reactive Protein metabolism, Case-Control Studies, Child, Female, Humans, Leukocyte Count, Male, Retrospective Studies, Appendicitis diagnosis, Lymphocytes metabolism, Mean Platelet Volume
- Abstract
Introduction: Mean platelet volume - to -lymphocyte ratio (MPVLR) has emerged as a novel parameter of inflammation and thrombosis. The aim was to evaluate whether MPVLR has a role in the diagnosis of childhood appendicitis., Population and Methods: Retrospectively reviewed the medical records up to 18 year with suspected acute appendicitis (AA) who underwent appendectomy between January 2016 and December 2017. Based on histopathological evaluation, the patients were classified into normal appendix, and simple and perforated appendicitis. Preoperative mean platelet volume (MPV), platelet distribution width (PDW), MPVLR, platelet-to-lymphocyte ratio (PLR), counts of platelets and white blood cells (WBC), and C-reactive protein (CRP) levels were measured., Results: A total of 219 children with clinically suspected AA who underwent surgical treatment for appendicitis were reviewed, and 100 genderage matched healthy subjects were included. Compared with the controls, the mean levels of MPVLR, PLR, WBC and CRP were significantly higher in the children underwent appendectomy (p <0.001). These values were significantly higher in simple appendicitis than in normal appendices (p<0.01). Compared with simple appendicitis, these levels were significantly higher in the children with perforated appendicitis (p <0.001). The area under curves for MPVLR and PLR were 0.771 and 0.726 in the prediction of appendicitis and 0.693 and 0.722 in the prediction of perforation, respectively., Conclusions: Increased level of MPVLR may be valuable for aiding the diagnosis of pediatric AA. In addition , it can help discriminate simple and perforated appendicitis in children., Competing Interests: The authors report no conflicts of interest in this work., (Sociedad Argentina de Pediatría.)
- Published
- 2019
- Full Text
- View/download PDF
49. Antifungal consumption, indications and selection of antifungal drugs in paediatric tertiary hospitals in Turkey: Results from the first national point prevalence survey.
- Author
-
Çağlar İ, Devrim İ, Özdemir H, Şahbudak Z, Sönmez G, Buyukcam A, Gulhan B, Kara A, Aygun DF, Bayram N, Celebi S, Çetin B, Nepesov MI, Yilmaz AT, Kepenekli E, Çiftdogan DY, Acar MK, Yayla BC, Okumuş C, Ecevit Z, Hatipoglu N, Kuyucu N, Kosker M, Sen S, Karbuz A, Sutcu M, Duramaz BB, Özen M, Çiftçi E, Alabaz D, Kurugol Z, Kara A, Kanik S, Kilic O, Oncel S, Somer A, Tapisiz A, Belet N, Akcan ÖM, Türel Ö, Ozkaya A, Tezer H, Cengiz AB, İnce E, Camcioglu Y, Kocabas E, Arisoy ES, and Salman N
- Subjects
- Drug Prescriptions statistics & numerical data, Hospitals, Pediatric statistics & numerical data, Humans, Prevalence, Surveys and Questionnaires, Tertiary Care Centers statistics & numerical data, Turkey, Antifungal Agents therapeutic use
- Abstract
Objectives: The aim of this point prevalence survey was to evaluate the consumption, indications and strategies of antifungal therapy in the paediatric population in Turkey., Methods: A point prevalence study was performed at 25 hospitals. In addition to general data on paediatric units of the institutes, the generic name and indication of antifungal drugs, the presence of fungal isolation and susceptibility patterns, and the presence of galactomannan test and high-resolution computed tomography (HRCT) results were reviewed., Results: A total of 3338 hospitalised patients were evaluated. The number of antifungal drugs prescribed was 314 in 301 patients (9.0%). Antifungal drugs were mostly prescribed in paediatric haematology and oncology (PHO) units (35.2%), followed by neonatal ICUs (NICUs) (19.6%), paediatric services (18.3%), paediatric ICUs (PICUs) (14.6%) and haematopoietic stem cell transplantation (HSCT) units (7.3%). Antifungals were used for prophylaxis in 147 patients (48.8%) and for treatment in 154 patients (50.0%). The antifungal treatment strategy in 154 patients was empirical in 77 (50.0%), diagnostic-driven in 29 (18.8%) and targeted in 48 (31.2%). At the point of decision-making for diagnostic-driven antifungal therapy in 29 patients, HRCT had not been performed in 1 patient (3.4%) and galactomannan test results were not available in 12 patients (41.4%). Thirteen patients (8.4%) were receiving eight different antifungal combination therapies., Conclusion: The majority of antifungal drugs for treatment and prophylaxis were prescribed in PHO and HSCT units (42.5%), followed by ICUs. Thus, antifungal stewardship programmes should mainly focus on these patients within the availability of diagnostic tests of each hospital., (Copyright © 2018 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
50. Relationship between mean platelet volume-to-lymphocyte ratio and coronary artery abnormalities in Kawasaki disease.
- Author
-
Bozlu G, Karpuz D, Hallioglu O, Unal S, and Kuyucu N
- Subjects
- Child, Child, Preschool, Echocardiography, Female, Humans, Infant, Logistic Models, Lymphocyte Count, Male, Mean Platelet Volume, Multivariate Analysis, Platelet Count, ROC Curve, Retrospective Studies, Turkey, Coronary Vessel Anomalies diagnostic imaging, Mucocutaneous Lymph Node Syndrome blood, Mucocutaneous Lymph Node Syndrome diagnostic imaging
- Abstract
Objectives: Recently, mean platelet volume-to-lymphocyte ratio has emerged as a novel parameter of inflammation. No study has investigated the role of mean platelet volume-to-lymphocyte ratio in children with Kawasaki disease. We aimed to evaluate the relationship between mean platelet volume-to-lymphocyte ratio and coronary artery abnormalities in Kawasaki disease., Methods: Between January 2008 and January 2017, a total of 58 children with Kawasaki disease and 42 healthy subjects matched for sex and age were enrolled. Before the treatment, transthoracic echocardiography for all children was performed. Clinical and laboratory results including mean platelet volume, platelet distribution width, red blood cell distribution width, and counts of platelets, neutrophils, lymphocytes, and white blood cells, erythrocyte sedimentation rate, and C-reactive protein levels were measured. Mean platelet volume-to-lymphocyte ratio was calculated as mean platelet volume divided by lymphocyte count., Results: Compared with healthy controls, mean platelet volume-to-lymphocyte ratio was significantly lower in the children with Kawasaki disease (p<0.01). A total of 14 patients (24.1%) had incomplete Kawasaki disease and 15 (25.8%) children with Kawasaki disease had coronary involvement. Mean platelet volume-to-lymphocyte ratio was significantly lower in patients with coronary artery abnormalities (p<0.01). According to receiver operating characteristic curve analysis performed for the prediction of coronary artery abnormalities, the best cut-off point for mean platelet volume-to-lymphocyte ratio was 2.5 (area under curve=0.593, sensitivity 53.3%, specificity 51.1%)., Conclusion: It was first shown that the children with Kawasaki disease have lower mean platelet volume-to-lymphocyte ratio compared with control subjects. Mean platelet volume-to-lymphocyte ratio may be helpful in predicting coronary artery lesions in patients with Kawasaki disease.
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.